rfhg_199047.1

Basic information about the TSS

---

TSS ID: rfhg_199047.1 Species: human Chr: chr17		Start: 77280629 End: 77280660 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D2965396,EH38E1887880)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000589070.1:-60 GeneID: 10801 HGNC/MGI_ID: HGNC:7323 UniProt_ID: K7EJV0 Nearer transcript ids and distances:

Gene_name: septin 9 Gene_symbol: SEPTIN9 Gene_synonyms: AF17q25 KIAA0991 MSF1 PNUTL4 SeptD1 Gene_source: HGNC:7323

TATA-Box annotation

---

Distance to TSS:	-855
Nearest PromoterID:	NM_001113491
Entrez ID:	10801
Nearest Unigene:	Hs.440932
Nearest Refseq:	NM_006640
Nearest Ensembl:	ENSG00000184640
Gene Name:	septin 9
Gene Alias:	AF17q25|MSF|MSF1|NAPB|PNUTL4|SEPT9|SINT1|SeptD1
Gene Type:	protein-coding
CpG%:	0.032258
GC%:	0.406250
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SEPTIN9 p2@SEPTIN9 p3@SEPTIN9 p4@SEPTIN9 p5@SEPTIN9 p6@SEPTIN9 p7@SEPTIN9 p8@SEPTIN9 p9@SEPTIN9 p10@SEPTIN9
Sample		p1@SEPTIN9	p2@SEPTIN9	p3@SEPTIN9	p4@SEPTIN9	p5@SEPTIN9	p6@SEPTIN9	p7@SEPTIN9	p8@SEPTIN9	p9@SEPTIN9	p10@SEPTIN9
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	21.04	26.88	4.29	2.53	0.19	2.73	0.97	0.00	0.19	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	18.01	30.15	3.44	2.02	0.00	2.43	0.81	0.40	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	18.52	32.41	3.09	1.93	0.00	2.51	0.96	0.19	0.39	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	15.18	24.12	4.37	2.49	0.42	2.49	1.25	0.00	0.62	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	17.10	27.45	4.05	0.90	0.00	4.05	1.57	0.22	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	13.37	24.81	4.65	1.55	0.58	2.13	0.78	0.39	0.00	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	8.28	38.35	3.92	3.05	0.22	6.75	1.96	0.00	0.22	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	8.48	45.54	4.12	2.91	0.24	4.12	0.24	0.24	0.24	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	12.40	40.61	3.21	3.63	0.00	5.56	1.71	0.21	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	4.06	27.82	2.32	2.90	0.00	4.06	2.90	0.58	0.58	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	4.04	28.30	4.45	4.04	0.00	6.47	4.85	0.00	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	5.69	23.17	2.03	2.85	0.41	5.29	3.25	0.00	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	2.26	289.18	2.58	3.71	0.00	1.61	0.81	1.93	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	2.26	229.89	2.26	2.41	0.15	1.20	0.75	2.56	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	1.54	221.75	1.98	3.07	0.00	2.20	1.10	2.63	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	2.01	231.62	2.77	3.27	0.00	1.26	0.50	1.76	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	1.53	228.24	2.40	2.18	0.00	1.53	0.87	1.75	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	0.84	242.97	2.53	1.27	0.00	2.53	0.42	2.95	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	2.13	209.53	2.67	4.27	0.00	2.67	1.07	1.07	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	2.41	242.21	2.11	3.31	0.00	2.11	0.45	1.96	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	1.87	245.52	2.27	2.94	0.27	3.47	0.27	2.41	0.13	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	2.24	235.11	1.73	3.80	0.00	4.14	1.04	2.76	0.17	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	3.23	236.15	2.97	2.71	0.13	3.49	0.78	2.84	0.13	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	1.70	247.28	1.94	2.43	0.24	3.40	0.49	2.43	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	2.58	247.93	2.32	3.10	0.00	1.81	0.77	2.06	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	2.22	216.81	2.53	2.53	0.00	4.43	0.63	1.58	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	2.20	241.76	2.75	0.55	0.55	2.20	1.65	2.75	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	1.89	265.46	1.89	3.06	0.00	4.72	0.94	1.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	1.29	209.17	1.78	3.39	0.16	1.45	1.13	0.97	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	2.90	230.37	3.26	3.08	0.00	2.71	1.09	1.45	0.00	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	1.88	232.58	2.72	3.35	0.00	1.88	1.05	2.30	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	1.56	215.90	3.32	2.74	0.00	3.52	0.59	1.76	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	1.69	231.92	1.69	1.48	0.00	2.32	1.06	2.53	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	0.82	221.02	1.48	3.30	0.33	4.12	1.32	3.13	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	3.18	236.73	2.80	2.62	0.19	4.67	0.56	1.31	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	2.30	255.24	1.15	2.68	0.00	2.87	0.96	2.11	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	1.43	237.49	1.23	3.88	0.61	3.27	1.23	2.86	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	2.01	239.57	3.63	2.22	1.21	3.63	0.40	1.81	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	2.16	241.74	2.43	3.51	0.54	3.24	1.35	3.51	0.00	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	1.68	206.45	2.16	5.04	0.24	4.32	1.44	2.40	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	2.12	221.61	2.12	5.18	0.47	4.00	0.47	2.82	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	1.46	202.76	2.05	2.93	0.29	4.54	0.73	2.93	0.00	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	0.84	230.72	2.74	3.16	0.21	3.16	0.21	2.32	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	1.75	238.46	2.10	4.37	0.17	5.59	0.35	2.80	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	2.01	233.30	2.81	5.62	0.60	5.62	1.81	1.61	0.20	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	3.49	203.80	2.09	3.26	0.47	3.49	1.16	3.26	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	1.68	229.59	1.44	4.80	0.72	4.08	1.44	1.20	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	1.79	200.59	2.38	2.98	0.00	2.38	1.49	2.38	0.00	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	1.91	216.15	2.15	4.31	0.48	2.39	0.96	1.91	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	1.42	196.33	2.02	3.84	0.20	2.02	0.20	2.02	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	2.25	254.96	2.25	2.87	0.20	3.69	0.20	2.66	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	2.45	266.63	2.22	4.67	0.67	3.34	1.33	3.78	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	41.98	0.00	27.98	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	2.84	241.66	4.97	4.61	0.35	3.90	2.13	1.42	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	0.66	177.29	0.99	2.32	0.33	3.31	0.66	1.66	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	0.84	109.06	0.00	7.55	0.84	5.87	0.00	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	1.38	119.86	2.30	3.67	0.00	2.76	0.46	4.59	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	3.24	164.00	3.24	2.27	0.32	2.59	1.30	4.21	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	2.89	179.53	2.25	2.25	0.64	2.57	1.93	2.25	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	2.51	145.22	1.26	5.97	0.31	4.09	0.00	3.14	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	4.23	116.33	4.94	2.82	0.00	2.12	1.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	2.80	104.87	1.68	4.49	0.56	2.80	2.80	3.36	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	0.80	104.29	5.57	7.17	0.00	3.18	0.80	1.59	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	4.42	89.70	4.42	4.76	0.34	1.36	1.36	2.04	0.00	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	5.52	129.97	4.22	3.90	0.00	1.62	2.27	1.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	7.81	89.10	2.48	4.26	0.71	6.03	0.71	4.26	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	32.33	0.00	0.00	0.00	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	86.87	0.00	15.79	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	5.36	109.20	2.44	4.88	0.98	4.39	0.98	1.46	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	6.94	97.19	3.47	7.44	0.99	5.95	1.98	2.48	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	8.91	90.54	1.41	7.51	0.00	6.10	3.28	1.88	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	4.64	90.75	0.99	13.25	0.33	11.92	0.66	2.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	3.40	101.15	1.55	6.19	1.24	6.81	3.40	2.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	4.59	108.54	2.14	11.62	0.00	4.89	3.06	2.75	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	19.48	0.16	0.32	9.82	15.20	6.18	5.23	0.00	0.00	0.00
Adipocyte - breast, donor2	11327-117E4	37.22	1.93	0.32	10.59	13.96	4.33	3.37	0.00	0.00	0.16
Adipocyte - omental, donor1	11473-119C6	34.35	1.65	0.13	8.14	16.16	4.07	4.07	0.13	0.00	0.13
Adipocyte - omental, donor2	11474-119C7	35.88	0.75	0.00	7.47	5.23	5.98	4.48	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	38.52	0.33	0.00	9.04	7.70	0.67	4.69	0.00	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	58.06	1.28	0.64	11.48	4.47	0.64	3.19	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	35.18	5.50	0.00	4.40	6.60	0.00	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	60.07	7.68	0.45	49.23	24.39	21.23	10.84	0.45	0.00	10.84
Adipocyte - subcutaneous, donor3	11408-118E4	90.02	0.00	0.87	6.78	13.73	0.35	0.52	0.00	0.00	1.91
Adipocyte differentiation, day04, donor1	13019-139D4	20.93	5.67	1.56	17.80	32.86	1.17	7.24	0.00	0.20	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	23.16	3.86	3.35	14.67	14.93	2.83	4.63	0.00	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	20.63	5.85	1.95	37.36	32.34	7.25	10.87	0.00	0.28	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	21.16	5.88	1.18	17.63	13.52	4.11	4.70	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	13.11	8.85	0.72	19.06	39.41	3.22	3.94	0.00	0.08	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	13.88	5.16	3.55	14.52	19.69	2.26	5.16	0.00	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	19.19	5.87	1.60	10.66	27.19	3.20	4.80	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	10.57	4.45	0.56	15.02	16.14	2.78	4.45	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	8.73	10.40	0.42	18.30	30.36	6.24	7.49	0.00	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	9.54	4.77	2.01	9.54	21.35	3.27	1.76	0.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	7.20	8.18	0.98	13.74	30.43	4.58	1.64	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	7.31	6.09	0.30	14.92	21.92	3.65	3.65	0.00	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	47.96	135.47	16.13	5.08	0.66	5.52	3.54	2.87	0.66	2.21
Alveolar Epithelial Cells, donor2	11590-120G6	21.87	338.50	10.40	4.66	0.36	13.27	2.51	3.59	0.00	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	76.67	68.29	1.20	4.79	1.20	3.59	1.20	2.40	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	28.78	55.77	17.45	14.39	7.56	32.92	14.93	20.33	0.72	8.64
Amniotic Epithelial Cells, donor2	11613-122A2	53.55	23.43	18.41	21.76	13.39	28.45	10.04	16.73	0.00	6.69
Amniotic Epithelial Cells, donor3	11694-123A2	32.87	33.69	6.78	17.26	7.60	29.58	13.97	26.09	0.21	2.47
Anulus Pulposus Cell, donor1	11248-116E6	113.17	8.93	14.07	13.04	27.35	4.58	5.61	3.43	1.03	23.91
Anulus Pulposus Cell, donor2	11463-119B5	155.76	14.45	9.80	16.16	23.02	4.90	5.14	3.92	1.22	18.12
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	69.19	3.59	2.25	14.38	15.28	6.74	8.09	1.80	0.45	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	75.97	0.87	4.34	9.12	10.85	3.04	7.81	0.00	0.43	2.17
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	66.35	2.14	2.14	12.84	8.56	4.28	2.14	0.00	0.00	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	62.18	2.69	4.18	13.75	13.75	4.78	5.68	0.90	0.30	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	77.14	2.53	2.53	11.38	15.18	3.79	7.59	1.26	0.00	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	57.43	1.98	1.98	9.24	5.94	1.98	5.28	0.66	0.00	1.98
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	61.08	2.60	2.60	9.75	13.00	2.92	4.87	0.97	0.00	1.95
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	62.14	2.91	4.37	12.14	13.59	3.88	6.80	1.46	0.00	3.40
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	57.01	0.59	4.16	8.31	5.94	3.56	5.94	0.59	0.00	1.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	74.20	2.26	5.65	10.17	12.81	4.90	7.16	1.13	0.00	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	47.89	2.18	4.35	7.98	13.79	0.73	11.61	1.45	0.00	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	63.94	0.00	0.00	6.27	7.52	6.27	7.52	2.51	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	60.46	1.48	2.47	8.90	11.20	2.64	6.10	0.82	0.16	2.64
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	54.59	4.09	2.73	6.82	10.92	4.09	8.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	50.21	0.90	1.96	9.05	6.33	2.71	6.48	0.90	0.15	3.17
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	67.51	0.00	2.68	11.79	9.11	3.75	7.50	0.54	0.00	2.68
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	72.17	1.51	1.70	10.20	11.15	3.78	4.91	0.76	0.00	3.21
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	71.10	2.41	3.74	9.09	10.16	2.94	8.82	1.07	0.00	1.60
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	53.65	2.93	2.93	10.73	9.75	3.90	8.78	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	72.31	2.16	2.32	11.44	8.62	2.82	6.80	1.33	0.17	3.15
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	56.43	2.40	3.60	4.80	6.00	6.00	6.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	53.10	10.62	0.00	0.00	17.70	7.08	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	64.50	3.09	3.77	10.46	8.92	4.12	6.18	1.54	0.00	1.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	46.14	4.19	4.19	8.39	4.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	76.70	3.40	3.40	13.59	11.16	4.37	6.31	1.94	0.49	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	82.34	1.52	4.17	11.00	15.18	5.69	6.83	1.14	0.38	2.28
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	61.78	2.42	4.85	10.90	6.06	1.21	7.27	1.21	0.00	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	79.80	1.14	3.42	10.26	9.69	5.70	10.26	0.57	0.00	2.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	79.10	1.50	2.57	10.26	11.33	4.49	4.70	0.43	0.21	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	69.43	1.29	1.55	5.68	8.00	1.29	5.42	0.26	0.00	3.36
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	78.36	2.82	3.28	10.32	7.51	3.28	6.57	0.94	0.00	2.35
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	82.00	2.25	1.61	9.97	9.32	3.22	5.79	0.32	0.00	1.93
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	56.36	0.71	1.43	6.42	4.28	3.57	4.28	0.00	0.00	4.99
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	68.44	2.34	2.92	9.94	11.11	2.92	5.26	1.17	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	78.28	2.11	3.61	7.53	10.54	4.82	6.92	0.60	0.30	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	76.03	3.56	1.19	14.26	2.38	7.13	4.75	1.19	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	77.30	4.58	2.54	10.17	10.17	3.56	9.66	0.51	0.00	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	79.46	1.27	2.55	10.70	9.42	5.86	7.64	0.76	0.00	3.06
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	68.62	1.27	3.81	5.72	7.62	1.91	5.08	0.00	0.00	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	69.05	1.73	4.75	12.08	9.49	3.02	9.06	0.00	0.43	1.73
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	70.49	0.85	3.81	9.74	7.83	3.18	6.56	0.42	0.00	2.54
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	58.87	1.45	3.19	4.93	7.25	2.90	8.41	0.87	0.00	1.74
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	77.47	1.89	5.67	11.34	8.50	3.78	7.56	0.94	0.94	2.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	64.76	2.20	3.90	8.31	9.49	4.75	6.61	0.85	0.17	2.20
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	81.07	2.32	6.95	6.95	2.32	4.63	13.90	2.32	0.00	6.95
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	71.83	4.23	4.23	6.34	6.34	2.11	8.45	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	79.12	2.57	4.29	10.51	9.65	3.86	7.72	1.07	0.21	2.79
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	64.98	2.41	1.80	6.02	4.81	6.62	6.62	1.20	0.00	3.61
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	60.51	3.64	1.46	8.02	10.93	2.19	11.66	0.00	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	82.76	1.61	3.45	8.97	11.26	7.13	6.21	0.46	0.00	2.76
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	56.11	2.55	0.00	10.20	5.10	2.55	5.10	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	45.00	1.27	2.03	6.86	6.10	3.31	3.81	0.76	0.00	2.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	83.81	2.89	3.72	12.39	14.24	3.30	6.61	0.83	0.00	1.24
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	72.52	2.14	3.98	10.10	8.57	3.98	6.12	0.61	0.00	1.84
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	62.14	2.39	2.87	10.52	8.13	4.78	5.26	0.96	0.00	3.82
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	77.83	3.10	2.88	10.64	10.20	2.88	3.99	0.44	0.00	2.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	47.30	4.58	1.53	4.58	15.26	3.05	1.53	0.00	0.00	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	54.28	2.77	1.66	12.19	8.86	2.22	6.09	0.00	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	75.47	1.06	3.44	9.00	11.12	3.44	7.15	1.06	0.00	2.38
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	58.15	1.82	1.82	9.09	7.27	3.27	4.00	0.00	0.00	1.09
Astrocyte - cerebellum, donor1	11500-119F6	166.78	34.51	21.98	5.40	0.61	1.47	0.86	5.16	2.33	18.42
Astrocyte - cerebellum, donor2	11580-120F5	209.50	104.24	21.22	6.85	0.17	3.08	1.03	4.11	1.03	14.21
Astrocyte - cerebellum, donor3	11661-122F5	111.59	18.04	4.61	1.47	0.42	0.00	1.05	1.26	0.42	2.10
Astrocyte - cerebral cortex, donor1	11235-116D2	81.92	15.69	40.78	1.39	0.70	0.00	0.35	0.00	1.39	16.38
Astrocyte - cerebral cortex, donor2	11316-117D2	132.01	35.91	34.46	1.13	0.32	1.46	0.16	2.75	3.72	19.74
Astrocyte - cerebral cortex, donor3	11392-118C6	74.58	16.11	31.32	7.91	2.68	5.52	2.39	2.83	2.83	12.68
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	1.61	27.41	164.92	17.32	4.70	28.10	0.34	0.00	65.26	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	1.25	25.93	161.11	17.54	3.76	21.92	0.63	0.00	47.48	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	1.14	24.69	159.54	13.54	5.69	21.05	0.68	0.00	61.56	0.68
Basophils, donor1	12241-129G9	55.44	0.78	92.84	4.71	0.26	4.18	0.52	0.00	6.80	0.00
Basophils, donor2	12242-129H1	56.28	0.00	88.03	3.97	0.00	1.80	0.00	0.00	3.61	0.00
Basophils, donor3	12243-129H2	63.06	2.79	135.53	7.94	2.06	6.47	0.29	0.29	6.47	0.73
Bronchial Epithelial Cell, donor1	11511-119G8	2.16	145.10	1.72	0.86	0.22	2.37	0.65	4.53	0.86	1.72
Bronchial Epithelial Cell, donor2	11591-120G7	3.20	369.41	5.03	0.46	0.00	0.91	0.00	4.57	1.83	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	150.64	7.17	0.00	0.00	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	5.02	251.06	5.65	3.14	0.00	2.51	0.00	9.41	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	2.91	262.64	7.49	0.62	0.00	0.83	0.00	8.11	0.21	1.46
Bronchial Epithelial Cell, donor6	11461-119B3	0.69	187.69	0.92	0.00	0.00	0.23	0.00	7.60	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	1.44	110.85	2.70	1.44	0.36	2.16	0.36	3.42	0.54	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.21	0.00	237.95	0.00	0.00	0.00	0.00	0.00	3.30	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	0.00	159.07	0.00	0.00	0.00	0.00	0.00	116.22	2.33
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	25.58	5.44	39.97	2.24	0.00	1.92	0.00	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	72.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	51.85	1.13	98.06	19.16	0.56	16.34	0.00	0.00	9.58	0.00
CD14+ Monocytes, donor2	11305-117B9	70.34	0.93	123.42	8.54	0.93	19.49	0.56	0.00	5.75	0.93
CD14+ Monocytes, donor3	11381-118B4	72.01	0.88	113.72	12.29	0.22	14.05	0.22	0.00	3.51	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	37.93	19.81	46.99	27.17	9.06	10.47	3.40	0.00	4.53	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	51.93	21.61	57.24	16.68	12.51	4.93	2.65	0.00	5.69	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	31.56	21.70	54.24	30.24	8.88	8.22	1.31	0.00	3.29	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	25.59	2.02	53.34	7.66	3.04	15.32	0.58	0.00	2.46	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	26.86	3.62	72.72	9.96	1.51	23.23	0.60	0.00	3.92	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	36.48	4.26	72.73	10.90	3.55	28.43	0.00	0.00	3.55	1.66
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	15.90	1.17	35.99	4.69	1.67	12.39	0.17	0.00	1.00	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	22.91	3.04	46.09	9.66	1.38	25.12	0.00	0.00	1.66	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	18.35	4.21	53.55	10.41	3.22	21.57	0.50	0.00	1.24	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	15.66	4.31	37.40	11.75	1.76	20.75	0.00	0.00	0.78	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	29.20	8.90	57.33	15.49	1.78	39.17	0.18	0.00	0.89	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	16.32	7.18	49.40	13.06	2.18	41.79	0.00	0.00	1.52	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	14.75	2.11	34.18	4.21	1.64	7.49	0.00	0.00	0.47	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	46.47	2.11	73.40	8.45	0.53	18.48	0.00	0.00	2.64	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	28.84	3.33	74.33	9.98	2.22	13.31	0.00	0.00	2.22	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	15.77	2.38	40.46	4.31	3.12	11.16	0.00	0.00	1.34	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	17.36	3.59	55.67	8.78	2.59	22.55	0.20	0.00	3.19	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	11.66	1.67	40.60	7.29	3.33	20.40	0.00	0.00	2.08	0.83
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	13.96	3.20	37.52	9.84	1.83	23.56	0.46	0.00	1.37	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	22.62	3.17	49.54	9.50	2.71	18.77	0.23	0.00	1.58	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	23.13	1.75	50.19	9.60	3.06	22.70	0.44	0.00	1.31	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	21.52	8.34	44.38	10.22	1.88	36.31	0.81	0.00	1.08	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	34.54	12.21	75.72	12.21	2.44	57.05	1.05	0.00	3.31	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	34.51	13.05	82.48	13.89	4.63	55.55	0.84	0.00	2.10	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	13.04	2.39	28.66	14.33	2.76	30.50	0.00	0.00	0.37	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	17.26	6.69	41.22	27.83	2.82	64.46	1.41	0.00	2.11	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	13.16	4.83	35.10	24.57	3.95	68.00	0.44	0.00	0.44	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	20.92	6.28	41.85	12.55	2.79	18.66	0.35	0.00	1.39	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	34.19	9.66	68.02	19.70	2.97	35.31	0.74	0.37	2.97	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	27.37	10.56	66.82	18.54	1.51	37.07	0.43	0.00	1.94	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	13.10	4.09	22.93	9.83	0.41	18.84	0.41	0.00	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	13.44	3.01	39.17	13.21	0.93	26.89	0.00	0.00	1.62	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	11.83	1.62	27.84	15.54	1.39	24.13	0.23	0.00	0.46	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	52.09	0.44	143.64	0.65	0.00	1.31	0.00	0.00	20.49	1.31
CD14+CD16+ Monocytes, donor2	11801-124D1	55.67	0.46	146.91	0.69	0.00	0.00	0.00	0.00	25.18	1.62
CD14+CD16+ Monocytes, donor3	11912-125G4	35.96	0.22	116.76	0.87	0.43	1.08	0.00	0.00	13.43	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	52.48	0.47	99.82	4.83	0.31	4.05	0.47	0.00	6.54	1.09
CD14+CD16- Monocytes, donor2	11799-124C8	34.06	0.35	89.24	3.49	0.00	1.40	0.00	0.17	7.34	1.22
CD14+CD16- Monocytes, donor3	11910-125G2	41.92	0.22	152.29	1.11	0.45	2.01	0.00	0.00	8.03	1.11
CD14-CD16+ Monocytes, donor1	11790-124B8	42.36	0.00	117.38	0.26	0.00	0.26	0.00	0.00	16.08	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	52.48	0.00	135.47	0.22	0.00	0.00	0.00	0.00	20.64	1.10
CD14-CD16+ Monocytes, donor3	11911-125G3	44.21	0.21	178.33	0.21	0.00	0.42	0.21	0.00	20.42	1.47
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	0.00	0.00	107.71	0.00	0.00	0.00	0.00	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	3.39	0.00	136.27	0.68	0.00	2.03	1.36	0.00	5.42	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	7.25	0.00	124.27	0.00	0.00	0.00	1.04	0.00	6.21	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	8.00	1.07	94.88	0.00	0.00	0.53	0.00	0.00	2.67	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	5.90	2.68	158.68	0.00	0.54	2.68	1.07	0.00	1.07	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	6.32	0.00	113.71	0.70	0.00	1.40	0.00	0.00	3.51	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	4.71	0.00	132.56	0.00	0.00	1.57	0.00	0.00	2.35	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	6.59	0.00	141.06	0.00	0.00	1.32	0.00	0.00	5.27	0.00
CD19+ B Cells, donor1	11544-120B5	8.22	0.82	272.05	0.82	0.00	3.29	1.64	0.00	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	23.94	0.00	242.29	0.73	0.00	2.90	0.73	0.00	7.25	0.73
CD19+ B Cells, donor3	11705-123B4	24.74	2.02	232.22	0.50	0.50	3.53	0.50	0.50	2.52	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	0.40	0.00	2.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	0.80	0.40	1.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	28.11	0.00	34.14	1.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	20.79	2.81	50.56	3.37	0.00	7.87	0.00	0.00	1.69	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	27.43	5.26	57.49	2.25	0.00	1.88	0.00	0.00	1.13	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	21.20	4.51	49.61	0.90	0.00	1.35	0.00	0.00	0.45	0.45
CD4+ T Cells, donor1	11225-116C1	158.89	0.71	338.85	0.00	0.00	0.00	0.00	0.00	9.28	0.00
CD4+ T Cells, donor2	11306-117C1	165.34	0.00	240.66	0.00	0.00	0.00	0.00	0.00	7.35	0.00
CD4+ T Cells, donor3	11382-118B5	208.92	0.00	257.11	0.00	0.00	0.00	0.00	0.00	13.11	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	39.82	0.26	285.86	0.00	0.00	0.00	0.00	0.00	29.61	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	25.60	0.45	259.41	0.22	0.00	0.22	0.00	0.00	25.38	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	36.51	0.00	346.39	0.00	0.00	0.00	0.00	0.00	29.61	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	25.13	0.00	221.40	0.00	0.00	0.00	0.00	0.00	12.33	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	23.88	0.00	182.60	0.00	0.00	0.00	0.00	0.00	8.43	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	26.37	0.00	306.55	0.00	0.00	0.00	0.00	0.00	13.18	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	135.27	0.87	127.03	0.00	0.00	0.00	0.00	0.00	29.34	1.01
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	75.92	0.51	156.92	0.17	0.00	0.00	0.00	0.00	36.60	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	92.37	0.97	158.79	0.00	0.00	0.32	0.00	0.00	23.05	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	38.11	0.00	197.70	0.00	0.00	0.00	0.00	0.00	10.76	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	33.89	0.00	201.60	0.00	0.00	0.00	0.00	0.00	7.69	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	40.04	0.00	298.75	0.00	0.00	0.00	0.00	0.00	14.52	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	195.22	4.64	235.28	0.00	0.00	0.42	0.00	0.00	26.14	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	196.97	0.42	125.91	0.00	0.00	0.00	0.00	0.00	9.97	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	194.46	1.00	130.31	0.00	0.00	0.33	0.00	0.00	10.02	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	147.93	0.00	329.04	0.00	0.00	0.27	0.00	0.00	18.49	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	107.73	0.00	306.56	0.00	0.00	0.00	0.00	0.00	12.86	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	177.53	0.00	387.34	1.79	0.00	0.00	0.00	0.00	17.93	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	261.82	0.93	153.16	0.19	0.00	0.00	0.00	0.00	25.59	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	188.46	0.22	111.77	0.00	0.00	0.00	0.00	0.00	13.21	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	242.09	0.42	147.74	0.00	0.00	0.00	0.00	0.00	8.62	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	79.38	0.00	153.70	0.51	0.00	0.51	0.00	0.00	4.04	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	71.92	0.00	131.28	0.00	0.00	0.00	0.00	0.00	3.03	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	138.59	0.00	254.95	0.00	0.00	0.00	0.00	0.00	11.33	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	93.53	0.00	203.39	0.99	0.00	0.00	0.00	0.00	7.92	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	65.55	0.00	162.48	0.00	0.00	0.00	0.00	0.00	2.77	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	60.02	1.40	160.52	0.00	0.00	0.00	0.00	0.00	6.98	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	111.88	0.55	236.50	0.83	0.00	0.28	0.00	0.00	6.65	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	127.11	0.25	290.54	0.49	0.00	0.25	0.00	0.00	9.57	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	97.02	0.00	160.16	0.00	0.00	0.00	0.00	0.00	4.62	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	99.56	0.00	182.28	0.36	0.00	0.00	0.00	0.00	7.16	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	81.71	0.00	132.96	0.00	0.00	0.00	0.00	0.00	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	103.78	0.00	186.29	0.33	0.00	0.00	0.00	0.00	2.62	0.00
CD8+ T Cells, donor2	11307-117C2	137.03	0.00	168.19	0.38	0.00	0.00	0.00	0.00	1.50	0.00
CD8+ T Cells, donor3	11383-118B6	176.74	0.25	243.90	0.00	0.00	0.00	0.00	0.00	5.05	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	17.43	0.46	66.75	0.69	0.23	1.15	0.00	0.00	17.66	1.61
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	13.66	0.48	48.89	2.16	0.00	1.20	0.00	0.00	18.93	1.44
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	14.50	0.27	50.89	0.55	0.00	1.37	0.00	0.00	24.35	1.92
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	16.81	0.30	59.44	1.80	0.00	2.40	0.00	0.00	19.21	2.10
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	18.48	1.20	57.12	2.64	0.00	1.92	0.00	0.00	19.92	3.36
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	17.96	1.14	62.30	2.05	0.23	1.82	0.00	0.00	24.10	3.41
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	19.77	0.87	66.05	0.87	0.00	0.87	0.00	0.00	20.64	1.09
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	22.11	0.00	66.85	0.79	0.00	0.26	0.00	0.00	18.42	1.84
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	17.12	0.23	75.75	2.35	0.23	1.41	0.00	0.00	22.04	1.88
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	15.40	0.30	85.73	2.11	0.00	0.91	0.00	0.00	26.26	2.42
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	17.43	0.00	70.30	2.03	0.29	0.58	0.00	0.00	29.05	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	17.85	0.00	72.20	2.66	0.00	1.87	0.00	0.00	28.24	1.33
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	19.26	0.44	47.28	0.44	0.00	0.44	0.00	0.00	21.89	2.63
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	22.32	0.00	49.19	0.91	0.00	0.46	0.00	0.00	25.05	2.28
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	21.63	0.00	44.01	1.49	0.00	0.00	0.00	0.00	14.17	4.48
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	22.69	1.08	61.95	2.16	0.36	2.16	0.00	0.00	23.05	3.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	18.70	0.29	69.92	2.59	0.00	0.86	0.00	0.00	17.26	2.30
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	16.97	0.71	56.57	1.41	0.24	1.89	0.00	0.00	23.10	2.83
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	19.01	0.00	76.37	2.22	0.00	0.63	0.00	0.00	21.55	1.90
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	23.07	0.00	59.36	2.46	0.31	0.62	0.00	0.00	16.61	1.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	18.59	0.64	65.72	0.96	0.00	0.32	0.00	0.00	15.07	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	13.77	0.00	55.84	1.15	0.38	0.38	0.00	0.00	25.24	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	14.19	0.00	55.96	2.36	0.00	1.18	0.00	0.00	25.22	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	12.10	0.00	55.97	3.03	0.00	0.00	0.00	0.00	19.67	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	11.24	1.61	42.56	0.80	0.00	0.80	0.00	0.00	20.07	4.01
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	13.99	0.00	48.26	0.00	0.00	0.70	0.00	0.00	22.38	3.50
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	15.03	2.00	56.10	1.00	0.00	0.00	0.00	0.00	23.04	4.01
Cardiac Myocyte, donor1	11525-119I4	144.39	42.04	1.83	20.11	20.11	12.79	21.93	0.00	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	81.03	30.63	21.74	5.93	8.89	0.99	3.95	0.49	1.98	9.39
Cardiac Myocyte, donor3	11686-122I3	61.14	43.57	5.47	7.16	5.26	1.47	4.31	0.53	0.21	6.42
Chondrocyte - de diff, donor1	11261-116G1	85.63	9.36	6.24	23.92	21.49	7.97	19.41	0.35	1.04	7.63
Chondrocyte - de diff, donor2	11338-117F6	94.53	2.13	2.84	10.31	28.43	3.20	8.88	1.07	0.00	5.33
Chondrocyte - de diff, donor3	11410-118E6	62.24	3.07	2.62	8.76	15.36	3.19	5.35	1.25	0.23	0.80
Chondrocyte - re diff, donor2	11339-117F7	14.32	5.37	2.69	17.01	8.06	8.95	13.43	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	37.61	5.66	0.81	25.48	21.03	13.75	7.28	2.02	0.00	2.02
Ciliary Epithelial Cells, donor1	11242-116D9	81.82	40.39	22.38	4.25	0.34	0.80	0.00	12.85	1.38	5.62
Ciliary Epithelial Cells, donor2	11323-117D9	66.69	60.50	13.68	2.35	0.86	0.43	0.00	9.62	1.07	4.70
Ciliary Epithelial Cells, donor3	11399-118D4	57.08	57.26	21.59	2.04	0.62	0.71	0.18	11.50	0.62	2.65
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	69.69	31.36	17.42	4.68	3.39	2.02	3.48	1.10	3.21	2.75
Corneal Epithelial Cells, donor1	11526-119I5	0.88	255.36	7.25	1.54	0.66	3.95	1.10	6.37	0.88	2.20
Corneal Epithelial Cells, donor2	11606-120I4	6.83	143.34	5.69	5.69	0.00	2.28	0.00	4.55	1.14	3.41
Corneal Epithelial Cells, donor3	11687-122I4	0.77	199.90	3.32	3.58	1.53	3.07	1.53	3.07	1.02	1.28
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	31.04	50.52	6.44	19.65	2.48	17.17	1.49	0.00	0.99	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	28.70	46.37	3.78	19.56	2.52	14.82	1.89	0.00	1.58	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	24.15	20.70	20.70	0.00	17.25	3.45	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	14.04	43.63	8.96	15.44	5.72	19.11	1.40	0.00	1.73	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	92.24	0.00	277.41	0.00	0.00	1.02	0.00	0.00	4.44	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	77.69	0.00	208.27	0.00	0.00	0.65	0.00	0.00	7.18	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	89.05	1.45	282.14	0.97	0.00	0.00	0.00	0.00	3.39	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	19.68	0.50	14.18	0.83	0.00	0.00	0.17	0.00	0.00	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	41.66	1.17	13.50	3.52	5.28	1.76	4.69	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	51.47	2.26	20.08	1.98	0.28	0.00	0.00	0.00	0.28	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	64.09	9.04	16.12	0.39	0.00	0.00	0.39	0.39	0.00	2.36
Endothelial Cells - Artery, donor1	11264-116G4	49.16	5.24	16.58	0.00	0.00	0.00	0.00	0.00	0.29	0.29
Endothelial Cells - Artery, donor2	11341-117F9	21.65	1.41	4.94	0.24	0.00	0.00	0.47	0.00	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	28.40	6.49	13.85	0.53	0.18	0.18	0.35	0.70	0.18	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	38.12	2.44	7.09	3.77	0.00	0.89	0.66	0.00	0.44	2.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	47.77	1.52	11.56	6.69	1.22	0.91	0.91	0.00	0.00	1.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	58.07	1.41	8.46	1.41	0.56	0.28	0.56	0.00	0.00	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	57.35	3.57	10.40	2.97	0.00	0.30	0.00	0.00	0.00	2.08
Endothelial Cells - Microvascular, donor2	11342-117G1	65.60	1.56	3.64	3.64	0.00	0.00	0.52	0.00	1.04	1.56
Endothelial Cells - Microvascular, donor3	11414-118F1	86.77	2.84	4.82	2.13	0.28	0.57	0.28	0.14	0.28	0.71
Endothelial Cells - Thoracic, donor1	11266-116G6	24.01	0.80	15.20	4.00	0.00	0.00	1.60	0.00	0.80	2.40
Endothelial Cells - Thoracic, donor2	11343-117G2	30.40	1.57	5.77	0.00	0.00	0.00	0.00	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	47.09	0.75	15.90	1.49	0.00	0.12	0.37	0.00	0.25	0.75
Endothelial Cells - Umbilical vein, donor2	11324-117E1	63.88	0.65	11.73	1.52	0.00	0.22	0.22	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	55.20	0.85	12.82	2.44	0.00	0.00	0.61	0.00	0.61	0.61
Endothelial Cells - Vein, donor1	11267-116G7	40.95	1.14	22.75	2.28	0.00	0.00	0.00	0.00	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	38.42	1.40	25.15	0.00	0.00	0.00	0.70	0.00	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	40.04	0.31	15.70	1.26	0.00	0.31	0.47	0.00	0.31	1.10
Eosinophils, donor1	12244-129H3	0.00	0.00	152.47	0.00	0.00	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	57.76	1.65	36.31	0.00	0.00	6.60	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	35.67	0.00	24.97	0.00	0.00	7.13	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	0.98	186.91	4.15	1.71	0.49	1.47	0.73	7.33	0.49	1.95
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	122.73	0.00	2.08	0.00	0.00	0.00	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	130.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	89.90	4.52	0.00	11.08	9.44	10.67	6.16	2.87	0.00	1.64
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	84.20	2.30	0.44	3.94	1.86	0.77	1.75	0.00	0.00	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	98.59	4.33	2.49	8.02	4.66	1.95	5.53	0.00	0.00	2.28
Fibroblast - Aortic Adventitial, donor1	11245-116E3	73.74	3.40	1.58	11.04	7.88	3.76	8.13	0.61	0.12	4.97
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	59.91	2.32	0.27	6.00	7.92	1.91	4.78	0.00	0.00	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	119.60	3.80	2.00	5.38	10.76	0.95	3.90	0.00	0.11	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	48.22	3.95	2.11	8.70	12.38	3.43	6.85	0.00	0.00	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	125.24	10.63	6.64	12.29	15.61	3.65	8.97	0.00	1.33	3.32
Fibroblast - Cardiac, donor1	11268-116G8	92.09	46.72	7.26	8.62	6.35	2.72	5.90	3.18	0.00	5.44
Fibroblast - Cardiac, donor2	11345-117G4	94.74	28.80	6.82	15.92	6.82	6.82	11.37	4.55	0.00	14.40
Fibroblast - Cardiac, donor3	11417-118F4	65.61	20.19	7.41	5.84	3.94	3.47	6.15	16.56	0.47	4.26
Fibroblast - Cardiac, donor4	11452-119A3	109.73	64.87	10.61	11.82	15.76	2.12	5.46	1.21	0.91	11.52
Fibroblast - Cardiac, donor5	11456-119A7	44.67	50.38	6.73	15.74	10.53	6.98	10.91	1.90	0.25	3.81
Fibroblast - Cardiac, donor6	11460-119B2	46.54	46.84	4.85	13.95	6.97	6.37	11.37	0.91	0.15	3.34
Fibroblast - Choroid Plexus, donor1	11492-119E7	212.37	10.85	30.15	13.40	24.92	3.22	16.61	4.69	5.49	88.97
Fibroblast - Choroid Plexus, donor2	11572-120E6	219.60	10.35	27.61	10.79	23.73	4.31	10.35	3.02	2.16	58.24
Fibroblast - Choroid Plexus, donor3	11653-122E6	32.23	45.41	8.79	16.11	19.04	5.86	4.39	4.39	0.00	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	184.05	2.31	15.22	19.83	22.14	5.07	16.84	1.38	1.61	6.23
Fibroblast - Conjunctival, donor3	11692-122I9	225.91	0.68	10.85	2.54	27.82	0.51	2.20	0.00	1.19	24.42
Fibroblast - Dermal, donor1	11269-116G9	82.17	7.28	3.99	27.70	26.30	13.62	7.75	0.23	0.23	9.63
Fibroblast - Dermal, donor2	11346-117G5	71.70	13.68	6.13	19.81	51.88	12.26	10.38	0.47	0.47	7.55
Fibroblast - Dermal, donor3	11418-118F5	95.98	2.54	2.18	18.62	45.57	9.07	7.13	0.12	0.73	6.77
Fibroblast - Dermal, donor4	11450-119A1	79.36	1.92	6.90	24.87	29.28	14.47	14.13	0.34	0.57	3.73
Fibroblast - Dermal, donor5	11454-119A5	70.13	5.06	6.11	29.48	41.69	25.64	17.27	0.00	0.35	4.19
Fibroblast - Dermal, donor6	11458-119A9	90.14	6.17	8.77	35.08	51.65	28.26	21.60	0.00	0.65	3.41
Fibroblast - Gingival, donor1	11237-116D4	183.87	3.12	2.08	28.94	38.73	14.37	8.12	0.21	0.62	2.71
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	281.65	2.62	11.79	19.13	35.89	8.65	8.38	0.26	1.83	8.12
Fibroblast - Gingival, donor2	11318-117D4	170.26	8.70	9.88	27.41	31.76	15.29	15.02	0.92	0.13	4.48
Fibroblast - Gingival, donor3	11394-118C8	261.92	2.32	1.35	28.33	58.79	9.96	5.22	0.48	0.39	1.84
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	137.13	2.08	1.04	17.66	46.75	1.04	8.31	0.00	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	133.56	0.70	1.76	7.93	26.25	1.06	4.41	0.35	0.18	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	207.97	2.65	2.96	19.02	35.39	8.57	13.10	1.09	0.78	1.87
Fibroblast - Gingival, donor6 (control)	11922-125H5	184.99	3.11	2.16	23.53	44.76	12.58	13.79	0.95	0.54	1.08
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	172.56	6.00	1.76	12.35	53.99	9.88	19.76	4.94	0.35	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	186.46	5.12	3.80	28.66	47.38	14.92	14.92	1.90	0.29	4.39
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	158.17	3.82	1.77	23.04	45.27	17.86	16.64	1.09	0.41	1.23
Fibroblast - Gingival, donor8 (control)	11926-125H9	153.57	3.51	1.43	33.13	46.73	19.20	18.76	0.66	0.00	0.99
Fibroblast - Gingival, donor9 (control)	11927-125I1	251.36	0.59	3.52	16.14	46.08	1.03	3.96	0.44	0.15	0.59
Fibroblast - Lung, donor1	11270-116H1	269.15	25.83	5.44	14.95	12.23	2.72	6.80	2.72	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	261.13	53.72	7.46	10.45	11.94	1.49	2.98	0.00	1.49	4.48
Fibroblast - Lung, donor3	11419-118F6	265.91	64.79	9.71	11.82	12.24	3.80	2.53	0.42	0.42	3.38
Fibroblast - Lymphatic, donor1	11506-119G3	183.26	38.32	12.50	47.48	47.48	24.16	39.15	0.00	3.33	36.65
Fibroblast - Lymphatic, donor2	11586-120G2	138.46	12.59	9.79	25.18	13.99	2.80	15.38	1.40	0.00	9.79
Fibroblast - Lymphatic, donor3	11667-122G2	65.49	16.23	1.96	22.67	20.15	10.64	16.51	2.52	0.28	3.08
Fibroblast - Mammary, donor1	11540-120B1	138.84	25.98	2.84	45.87	71.04	11.37	27.61	7.31	0.81	2.44
Fibroblast - Mammary, donor2	11620-122A9	127.81	19.97	3.99	31.95	31.95	15.98	23.97	0.00	0.00	7.99
Fibroblast - Mammary, donor3	11701-123A9	125.08	5.96	0.00	17.87	47.65	0.00	11.91	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	152.66	2.33	8.34	28.13	30.84	4.27	14.16	0.39	0.00	5.04
Fibroblast - Periodontal Ligament, donor2	11319-117D5	238.29	6.52	10.47	32.91	46.11	12.59	18.81	0.46	0.76	7.28
Fibroblast - Periodontal Ligament, donor3	11395-118C9	164.01	3.06	0.92	34.27	52.63	18.67	14.99	0.31	0.31	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	218.67	3.43	2.67	24.42	37.78	6.11	10.30	2.29	0.00	1.53
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	159.56	2.16	0.27	19.98	42.93	8.37	6.48	3.51	0.00	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	144.85	1.62	1.28	14.96	23.19	4.06	4.87	0.81	0.00	1.62
Fibroblast - Pulmonary Artery, donor1	11250-116E8	29.51	53.28	4.64	9.06	4.75	5.31	6.08	2.10	0.33	5.31
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	299.50	20.12	16.26	23.77	22.15	14.02	18.69	3.05	3.45	13.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	186.43	18.71	10.02	34.75	64.15	19.38	16.71	4.01	1.34	26.73
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	139.56	5.93	6.72	15.02	36.37	7.51	5.54	0.40	0.00	14.63
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	58.94	17.07	1.79	21.43	28.97	29.97	22.23	1.59	0.00	1.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	96.27	3.02	0.53	12.79	28.42	4.44	7.28	1.42	0.00	1.60
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	112.14	1.77	1.18	15.18	31.93	6.50	8.87	0.79	0.59	2.96
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	49.34	13.24	0.90	17.15	29.48	25.57	24.97	0.30	0.00	1.81
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	126.95	9.61	1.73	28.07	50.74	12.09	13.93	0.54	0.76	3.02
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	47.83	12.65	0.51	10.63	43.78	16.96	24.55	6.58	0.25	2.02
Fibroblast - skin normal, donor1	11553-120C5	74.16	11.81	1.80	21.33	38.23	13.45	15.75	5.25	0.33	4.59
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	38.90	3.61	1.40	19.45	21.45	16.44	19.25	0.00	0.00	1.80
Fibroblast - skin normal, donor2	11561-120D4	52.14	2.01	1.81	15.17	19.19	11.15	11.85	0.20	0.40	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	82.81	14.51	0.60	20.25	43.52	26.60	24.18	0.91	0.60	3.02
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	123.11	3.73	0.75	16.57	44.82	5.14	7.37	0.83	0.08	1.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	257.28	1.03	9.92	10.77	23.25	1.71	10.60	0.00	2.39	15.73
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	54.52	6.24	0.33	22.00	20.03	20.69	23.98	0.99	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	58.80	5.43	1.81	32.92	20.77	26.42	19.39	2.24	0.00	1.17
Fibroblast - skin walker warburg, donor1	11554-120C6	97.67	19.74	5.40	31.88	24.96	22.43	21.42	3.88	0.34	4.55
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	31.05	6.74	0.63	18.35	17.56	13.80	10.66	3.92	0.00	1.41
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	22.16	66.48	22.16	44.32	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	13.94	61.88	5.23	9.59	4.36	19.17	5.23	2.61	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	0.00	140.42	3.29	1.56	0.35	1.39	0.52	8.84	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	0.00	152.50	2.60	1.04	0.00	0.52	0.00	8.85	0.52	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	0.00	154.33	2.04	1.79	0.51	1.02	0.26	9.45	0.00	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	97.23	72.73	60.48	0.77	0.00	0.00	0.00	0.00	5.36	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	65.08	51.68	38.28	0.00	0.00	0.00	0.64	0.64	5.74	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	81.01	56.77	54.49	0.00	0.00	0.00	0.29	1.43	2.28	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	176.21	28.13	71.97	0.00	0.00	0.00	0.00	0.28	3.31	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	97.04	14.84	65.99	0.00	0.00	0.00	0.00	0.46	2.28	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	107.98	53.30	55.87	0.00	0.00	0.00	0.20	0.40	2.97	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	169.97	28.55	74.28	0.00	0.00	0.00	0.00	0.53	6.34	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	92.63	11.74	82.19	0.00	0.33	0.00	0.00	0.00	4.24	2.94
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	72.08	60.58	29.63	0.00	0.00	0.00	0.00	0.00	1.77	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	71.93	42.40	40.84	0.00	0.00	0.00	0.00	0.71	8.34	2.97
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	70.68	45.44	39.90	0.49	0.49	0.25	0.37	1.23	7.63	3.69
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	65.01	48.62	38.41	0.00	0.00	0.27	0.00	0.27	7.79	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	73.96	40.76	47.45	5.08	1.12	1.73	1.12	2.23	12.64	14.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	58.14	65.34	42.50	2.77	0.28	1.52	0.69	1.52	12.04	10.66
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	49.20	56.31	33.54	1.02	0.00	0.61	0.00	0.61	12.60	5.49
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	73.47	52.94	41.07	3.65	4.34	2.51	1.60	3.88	9.58	9.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	64.40	59.54	41.85	3.36	1.12	2.49	0.12	3.36	9.97	10.21
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	72.35	85.46	34.97	2.84	0.22	2.40	0.22	2.62	11.37	5.90
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	70.62	27.48	45.50	5.02	9.16	1.48	6.80	3.55	7.09	7.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	70.10	30.36	48.16	5.25	6.04	1.91	2.38	4.29	7.63	5.88
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	84.01	51.16	38.43	1.56	0.45	1.79	0.45	4.02	8.04	7.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	62.91	16.33	50.21	9.07	19.96	3.23	11.09	4.44	7.66	7.46
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	66.67	16.96	54.96	9.67	13.23	1.02	4.41	2.71	8.82	8.65
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	77.14	48.41	59.23	7.18	11.62	1.68	4.79	4.70	18.71	13.57
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	81.37	15.19	77.21	14.15	57.02	3.85	18.94	8.64	13.32	12.38
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	85.22	14.86	65.07	15.88	56.36	6.49	19.64	6.15	9.56	15.03
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	57.21	8.08	50.13	9.85	31.20	3.87	8.52	2.77	6.97	7.19
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	58.24	23.29	46.26	6.24	24.04	1.58	3.33	3.00	14.89	12.15
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	66.15	23.48	59.21	8.17	24.71	2.65	4.08	4.90	13.68	12.86
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	73.65	7.63	44.15	8.87	22.90	6.81	10.93	3.71	2.48	5.78
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	78.63	9.57	55.46	9.22	26.52	4.38	10.49	5.07	5.07	6.69
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	57.87	9.51	55.03	12.01	41.86	5.00	6.00	3.67	11.17	9.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	51.58	7.49	36.15	13.45	37.91	3.97	10.80	4.19	2.65	8.60
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	52.52	7.50	45.75	9.72	42.68	3.94	11.56	4.30	3.07	5.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	79.59	11.99	49.11	8.92	34.53	4.05	4.86	2.92	10.70	7.62
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	59.97	11.23	32.71	13.79	38.81	3.85	8.34	3.21	4.17	4.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	47.28	5.97	39.61	13.27	34.49	5.69	10.71	2.75	6.44	5.31
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	41.44	3.95	55.20	15.66	48.24	2.53	9.49	3.32	11.71	11.86
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	50.48	7.91	39.53	13.38	39.53	11.25	17.64	3.04	4.56	7.60
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	46.00	4.60	38.78	19.03	29.38	8.26	10.77	3.24	6.06	10.66
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	38.64	9.00	46.11	7.68	44.57	3.29	7.25	1.76	7.90	7.25
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	44.33	10.66	28.34	13.47	28.34	7.86	10.10	2.52	2.52	6.17
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	36.76	3.24	57.03	21.02	54.44	7.13	14.91	2.59	5.93	10.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	29.95	2.67	54.02	16.04	66.32	6.15	7.22	2.14	8.02	10.96
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	33.66	4.28	50.95	26.32	52.63	7.34	11.93	2.60	9.03	16.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	33.94	2.33	49.48	18.65	49.35	5.96	7.25	2.72	6.35	10.88
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	30.09	3.25	45.27	10.57	88.64	2.44	6.78	1.90	5.96	3.25
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	71.53	4.24	32.45	14.38	54.94	6.08	14.56	4.98	2.21	5.35
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	73.25	5.04	22.81	11.62	49.78	3.29	14.69	3.29	1.32	6.36
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	81.32	4.96	62.48	13.88	138.84	0.99	6.94	2.98	4.96	3.97
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	100.78	4.49	22.69	13.32	43.66	4.22	14.38	5.54	1.06	6.07
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	117.83	4.04	15.74	13.92	40.75	4.04	14.12	5.45	1.21	6.05
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	145.89	16.52	126.06	11.95	181.72	2.54	15.50	5.34	7.62	24.15
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	64.69	65.29	35.63	0.00	0.00	0.00	0.00	0.60	2.99	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	49.15	50.69	30.51	0.00	0.00	0.00	0.00	0.15	2.00	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	69.56	61.99	51.96	0.00	0.00	0.00	0.00	0.61	0.82	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	57.27	36.61	61.02	0.00	0.00	0.00	0.00	0.31	6.88	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	59.62	37.01	45.77	0.00	0.00	0.00	0.00	0.00	4.52	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	71.95	61.34	61.80	0.00	0.00	0.00	0.00	0.00	4.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	66.82	39.60	54.45	0.00	0.00	0.00	0.00	0.00	9.90	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	97.48	49.90	63.82	0.00	0.00	0.00	0.00	0.39	10.06	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	105.89	25.67	65.78	0.00	0.00	0.00	0.00	0.00	6.42	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	121.72	36.52	41.73	0.00	0.00	0.00	0.00	0.00	3.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	90.16	39.06	48.50	0.00	0.00	0.00	0.00	0.00	9.44	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	82.77	37.06	50.65	0.00	0.00	0.00	0.00	0.41	7.82	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	146.62	26.66	69.98	0.00	0.00	0.00	0.00	0.00	13.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	112.98	31.04	59.84	0.00	0.00	0.00	0.00	2.52	16.50	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	103.61	40.20	58.83	0.00	0.00	0.00	0.00	0.00	18.96	2.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	147.64	33.55	67.11	0.00	0.00	0.00	0.00	0.84	16.78	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	152.04	25.76	78.25	0.00	0.00	0.00	0.00	2.54	19.40	3.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	133.49	29.89	72.01	0.00	0.00	0.00	0.00	2.38	20.04	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	123.20	18.79	77.26	0.00	0.00	0.00	0.00	2.09	12.53	6.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	160.36	20.62	94.50	0.00	0.00	0.00	0.00	2.29	18.90	5.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	136.45	23.68	77.25	0.00	0.00	0.00	0.00	0.89	15.39	7.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	118.59	18.64	72.85	0.00	0.00	0.00	0.00	0.00	15.25	13.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	159.88	25.27	98.58	0.00	0.00	0.00	0.00	0.83	15.74	9.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	143.83	19.10	106.78	0.00	0.00	0.00	0.00	1.38	16.80	6.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	126.44	21.07	68.49	0.00	0.00	0.00	0.00	0.00	21.07	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	103.79	17.68	78.04	0.00	0.00	0.00	0.00	1.54	8.46	8.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	109.53	18.58	74.65	0.33	0.00	0.00	0.00	1.96	15.32	12.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	97.65	19.40	46.82	0.00	0.00	0.00	0.00	3.34	2.68	6.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	106.72	31.21	73.59	0.39	0.00	0.00	0.00	3.08	11.17	8.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	122.22	42.45	72.23	0.00	0.00	0.00	0.00	2.05	13.01	22.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	144.12	37.27	64.60	0.00	0.00	0.00	0.00	7.45	9.94	29.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	125.51	25.01	80.69	0.47	0.00	0.00	0.00	1.42	8.97	8.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	95.35	33.19	70.61	0.00	0.00	0.00	0.00	4.83	4.83	10.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	108.35	27.47	78.34	0.00	0.00	0.00	0.00	3.05	9.16	12.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	118.06	26.32	83.76	0.00	0.00	0.00	0.00	5.58	11.17	7.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	85.84	24.67	86.34	0.00	0.00	0.00	0.00	2.47	7.40	13.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	118.04	34.23	57.84	0.00	0.00	0.00	0.00	2.36	10.62	10.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	120.19	21.59	79.93	0.00	0.00	0.00	0.00	4.08	8.17	7.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	87.78	37.74	56.62	0.44	0.00	0.00	0.00	1.76	7.90	7.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	87.31	34.76	50.86	0.00	0.00	0.00	0.00	4.24	8.48	7.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	80.58	28.05	60.29	0.00	0.00	0.00	0.00	1.79	4.78	5.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	74.73	15.53	63.08	0.00	0.00	0.00	0.00	1.94	7.28	7.76
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	53.64	5.71	4.57	18.26	44.51	6.85	6.85	5.71	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	67.78	2.49	3.33	8.73	19.96	4.16	7.48	2.49	0.00	2.08
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	119.19	13.49	5.62	20.24	37.11	21.36	20.24	5.62	0.00	3.37
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	73.26	3.49	0.00	7.61	27.91	2.54	4.44	0.63	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	124.49	2.92	1.67	10.44	31.75	5.43	5.43	0.42	0.00	2.51
Hep-2 cells mock treated, biol_rep1	11898-125E8	0.12	46.53	0.00	8.47	2.32	11.95	7.89	10.79	0.00	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	0.00	50.81	0.00	9.62	2.70	11.31	8.44	11.98	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	0.00	51.19	0.00	7.05	4.10	10.47	8.19	12.74	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	0.00	52.36	0.00	6.67	2.73	12.13	6.12	13.99	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	0.00	60.39	0.00	8.81	2.36	13.11	8.81	15.04	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	0.00	52.53	0.00	10.98	1.94	10.76	8.18	13.99	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	0.00	48.82	0.00	10.21	2.99	12.45	7.97	12.33	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	0.00	49.75	0.00	11.84	2.23	8.06	6.69	12.69	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	0.00	48.70	0.00	7.69	1.60	8.97	8.01	10.25	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	89.54	2.24	25.18	5.60	0.00	2.80	2.24	0.00	1.12	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	126.38	37.65	24.24	23.37	7.79	18.18	11.25	3.03	2.16	19.04
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	0.00	2.64	2.64	0.00	2.64	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	89.94	92.41	36.68	12.70	35.27	3.88	11.64	4.94	2.82	21.87
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	184.53	53.04	13.08	15.98	26.15	9.44	24.70	4.36	0.00	17.44
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	50.53	75.36	6.82	7.52	8.92	4.55	4.90	2.80	0.35	5.59
Hepatocyte, donor1	11523-119I2	0.00	64.16	2.42	0.00	0.00	0.00	0.00	13.32	2.42	0.00
Hepatocyte, donor2	11603-120I1	2.15	73.26	11.85	1.08	0.00	0.00	0.00	37.71	3.23	0.00
Hepatocyte, donor3	11684-122I1	9.20	47.24	6.14	3.68	0.00	0.61	0.00	14.11	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	77.67	30.02	206.90	0.00	0.00	0.00	0.00	0.00	1.31	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	0.00	241.55	15.73	1.40	0.00	4.02	0.35	1.57	4.19	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	64.49	31.83	12.35	6.59	3.02	1.37	5.21	6.59	1.10	4.25
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	22.29	12.74	6.37	12.74	0.00	15.92	15.92	0.00	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	20.03	20.03	13.35	6.68	20.03	13.35	0.00	13.35	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	54.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	9.69	6.92	6.92	12.46	1.38	11.08	20.77	0.00	2.77	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	5.01	5.01	17.52	2.50	5.01	5.01	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	11.87	0.00	11.87	0.00	23.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	15.38	10.25	5.13	10.25	0.00	12.81	25.63	0.00	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	18.28	4.57	0.00	0.00	13.71	9.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	19.49	14.62	9.75	14.62	3.25	14.62	8.12	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	13.34	11.67	10.00	13.34	3.33	11.67	15.01	0.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	36.31	7.26	3.63	18.15	0.00	7.26	7.26	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	6.62	18.53	6.62	10.59	1.32	11.91	19.85	0.00	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	11.09	13.30	6.65	14.41	1.11	14.41	18.85	0.00	2.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	36.67	0.00	5.24	5.24	10.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	12.60	12.60	10.08	9.45	3.15	10.71	8.82	0.00	1.26	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	12.37	7.73	7.73	12.37	7.73	13.92	12.37	0.00	3.09	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	14.63	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	14.86	12.27	10.34	7.75	6.46	11.63	12.27	0.00	0.65	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	17.71	16.10	11.27	19.32	1.61	8.05	11.27	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	23.90	0.00	11.95	0.00	0.00	35.84	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	12.22	21.19	9.78	12.22	0.00	11.41	16.30	0.00	3.26	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	17.21	13.85	13.43	11.75	1.26	11.75	15.11	0.00	2.94	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	28.74	14.37	0.00	0.00	14.37	28.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	24.11	6.43	14.47	10.45	4.82	10.45	12.86	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	24.93	12.00	7.39	12.00	0.92	13.85	6.46	0.00	0.00	2.77
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	15.08	30.16	0.00	15.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	15.11	6.61	12.75	9.44	2.83	9.44	8.97	0.00	1.42	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	19.95	14.51	8.16	7.26	5.44	16.33	10.88	0.00	1.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	29.48	0.00	0.00	0.00	0.00	29.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	24.75	7.53	15.07	4.30	2.15	20.45	4.30	0.00	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	22.87	17.79	12.70	12.70	2.54	13.98	7.62	0.00	5.08	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	16.43	0.00	0.00	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	20.41	17.22	11.48	10.84	1.91	12.75	11.48	0.00	2.55	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	27.34	14.58	16.40	12.76	3.65	5.47	5.47	0.00	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00	15.80	0.00	0.00	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	20.71	9.28	12.14	11.43	2.14	13.57	12.14	0.00	2.14	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	16.59	3.32	19.91	6.64	9.95	9.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	62.55	0.00	0.00	0.00	20.85	0.00	0.00	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	11.73	9.57	12.04	9.57	3.70	8.64	6.79	0.00	3.40	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	5.27	10.54	5.27	12.29	1.76	17.56	24.58	0.00	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	25.15	18.86	3.14	15.72	3.14	12.57	22.00	0.00	6.29	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	13.21	9.04	11.13	11.82	4.87	13.21	21.56	0.00	3.48	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	6.64	17.70	6.64	11.07	2.21	15.49	22.13	0.00	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	3.24	9.73	29.18	6.48	25.94	16.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	6.10	10.46	13.95	14.82	1.74	12.21	6.10	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	20.25	20.25	9.00	9.00	2.25	22.50	11.25	0.00	4.50	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	6.97	13.94	6.97	3.48	20.91	13.94	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	8.53	17.07	8.53	16.00	4.27	9.60	12.80	0.00	6.40	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	11.08	13.85	13.85	16.63	4.16	20.78	19.40	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	22.80	5.70	5.70	2.85	22.80	8.55	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	5.52	9.20	3.68	21.17	2.76	20.25	12.89	0.00	1.84	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	21.18	21.18	18.15	3.03	12.10	6.05	0.00	6.05	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	43.46	24.83	18.63	0.00	18.63	12.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	11.63	25.38	13.75	8.46	2.11	6.34	10.57	0.00	4.23	1.06
Keratinocyte - epidermal, donor1	11272-116H3	0.65	149.65	6.61	1.55	0.16	1.39	0.82	6.45	1.06	2.61
Keratinocyte - epidermal, donor2	11349-117G8	0.00	165.15	2.34	1.17	1.17	4.10	0.00	7.61	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	0.00	112.45	1.89	2.27	0.85	4.07	1.51	2.37	0.09	0.47
Keratinocyte - oral, donor1	11251-116E9	1.25	260.75	10.10	3.18	0.91	4.99	0.79	7.38	1.70	3.63
Keratocytes, donor1	11527-119I6	238.28	5.50	8.94	15.82	31.63	1.38	19.60	0.69	0.34	3.44
Keratocytes, donor2	11607-120I5	142.96	1.17	7.03	45.70	26.95	18.75	18.75	0.00	1.17	2.34
Keratocytes, donor3	11688-122I5	196.02	0.79	7.90	11.86	19.56	3.95	7.31	0.00	0.79	7.71
Krukenberg tumor cell line:HSKTC	10687-109F3	0.00	120.89	28.57	2.20	0.00	6.59	0.00	4.40	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	51.78	32.36	15.10	2.16	0.00	0.00	0.00	8.63	0.00	4.31
Lens Epithelial Cells, donor2	11609-120I7	83.15	17.18	26.87	3.00	0.35	0.35	0.00	3.11	1.27	4.50
Lens Epithelial Cells, donor3	11690-122I7	41.78	36.93	11.20	7.47	3.13	2.22	3.63	8.68	0.10	5.45
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	40.43	3.79	14.23	3.08	0.36	0.71	0.59	0.00	0.71	2.13
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	36.00	1.67	4.47	1.12	0.28	1.12	0.00	0.00	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	43.92	1.26	5.51	1.26	0.16	0.31	0.00	0.00	0.31	0.94
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	27.96	2.69	16.13	3.76	0.54	0.54	0.00	0.00	1.61	2.15
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	42.86	1.26	3.47	2.84	0.32	0.00	0.63	0.00	0.00	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	40.21	1.19	7.55	1.19	0.11	0.32	0.22	0.00	0.43	0.43
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	24.62	2.46	9.44	2.87	0.00	0.41	0.41	0.00	0.00	1.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	35.90	2.02	5.81	1.01	0.00	0.76	0.00	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	43.91	1.55	7.46	1.55	0.00	0.28	0.28	0.00	0.42	1.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	27.69	1.98	7.52	1.19	0.00	0.40	0.79	0.00	0.79	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	39.55	0.97	3.88	0.97	0.19	0.39	0.00	0.00	0.58	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	43.32	1.85	8.52	1.11	0.00	0.37	0.00	0.00	0.19	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	26.48	1.05	9.41	0.70	0.00	0.35	0.35	0.00	0.00	1.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	38.88	2.39	2.62	2.15	0.00	0.72	1.43	0.00	0.24	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	38.87	1.51	9.48	1.37	0.00	0.27	0.27	0.00	0.69	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	29.87	0.31	11.09	1.54	0.00	0.31	0.00	0.31	0.62	1.85
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	36.16	1.56	6.23	1.25	0.00	0.31	0.94	0.00	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	47.39	2.56	6.04	0.91	0.00	0.55	0.55	0.00	0.91	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	31.92	2.63	9.22	1.32	0.33	0.33	0.00	0.00	1.97	2.30
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	40.12	1.76	4.10	1.76	0.00	0.59	0.59	0.00	0.00	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	46.55	1.74	9.46	1.24	0.25	0.25	0.25	0.00	0.25	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	30.55	1.45	12.61	1.45	0.00	0.48	0.48	0.00	0.48	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	32.32	1.08	5.12	1.62	0.27	1.08	0.54	0.00	0.00	1.08
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	44.05	1.67	8.17	1.36	0.00	0.30	0.15	0.00	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	22.81	1.04	12.96	3.11	0.00	1.04	0.00	0.00	1.56	2.59
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	34.13	2.09	3.77	1.47	0.21	0.63	0.42	0.21	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	51.88	1.20	7.37	1.05	0.00	0.15	0.15	0.15	0.15	1.05
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	23.39	2.75	11.01	1.38	0.69	0.00	0.00	0.00	0.00	2.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	34.62	0.94	4.89	2.45	0.56	0.94	0.00	0.00	0.00	0.94
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	50.47	1.59	7.00	1.70	0.00	0.42	0.00	0.00	0.64	1.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	25.20	0.97	8.24	2.42	0.48	1.45	1.45	0.00	0.97	2.91
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	31.42	1.32	3.64	0.66	0.00	0.00	0.00	0.00	0.33	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	57.86	1.73	6.94	1.36	0.00	0.12	0.25	0.00	0.37	1.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	37.76	1.11	12.96	2.59	0.74	1.11	0.00	0.00	0.37	1.85
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	28.41	1.24	3.21	1.48	0.00	0.74	0.00	0.00	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	51.15	1.92	7.01	1.51	0.00	0.14	0.27	0.00	0.55	0.69
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	32.81	2.25	14.15	1.61	0.00	0.96	0.00	0.00	0.96	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	37.13	1.83	3.04	1.22	0.30	0.30	0.00	0.00	0.00	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	42.27	0.98	8.26	0.70	0.00	0.28	0.00	0.00	0.28	1.54
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	24.53	1.78	11.38	1.78	0.00	0.00	0.71	0.00	0.71	1.78
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	35.39	1.45	2.91	1.94	0.00	0.48	0.00	0.00	0.97	1.45
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	48.86	0.78	9.18	1.40	0.00	0.31	0.00	0.00	0.47	0.93
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	23.28	0.72	8.95	2.15	0.00	0.72	0.00	0.00	0.36	1.79
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	45.41	0.98	3.59	1.31	0.33	0.65	0.00	0.00	1.31	1.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	47.32	1.18	8.24	0.94	0.00	0.24	0.00	0.00	0.47	0.94
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	46.78	1.86	15.59	2.60	0.25	1.36	0.87	0.00	0.62	2.60
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	40.21	1.02	4.35	0.26	0.00	0.26	0.00	0.00	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	55.49	1.19	9.55	0.90	0.00	0.30	0.60	0.00	0.30	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	0.00	154.09	0.00	0.00	0.00	0.00	0.00	13.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	0.00	197.92	0.00	0.00	0.00	0.00	0.00	16.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	0.00	146.96	0.00	0.00	0.00	0.00	0.00	13.36	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	0.00	252.61	0.00	0.00	0.00	0.42	0.00	20.73	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	0.00	216.62	0.00	0.00	0.70	0.00	0.00	16.88	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	0.00	174.65	0.00	0.00	0.00	0.00	0.00	26.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	0.00	208.68	0.52	0.52	0.00	0.00	0.00	17.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	0.00	202.21	0.00	1.19	0.00	0.00	0.00	15.46	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	0.00	179.14	0.00	0.00	0.00	0.23	0.00	19.68	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	0.00	174.21	0.00	0.00	0.29	0.29	0.00	16.87	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	0.00	167.46	0.00	0.00	0.00	0.00	0.00	12.15	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	0.00	265.96	0.00	0.00	0.00	0.14	0.00	29.26	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	0.00	221.84	0.00	0.51	0.00	0.51	0.00	23.11	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	0.00	181.72	0.00	0.00	0.00	0.00	0.00	17.29	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	0.00	155.25	0.00	0.00	0.00	0.00	0.00	9.99	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	0.00	220.56	0.00	0.00	0.00	0.51	0.00	20.88	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	0.00	187.30	0.00	0.27	0.00	1.07	0.00	14.94	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	0.00	190.83	0.19	0.19	0.00	0.19	0.00	21.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	0.00	226.40	0.00	0.00	0.00	0.00	0.00	27.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	0.00	256.04	0.00	0.00	0.00	0.00	0.00	13.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	0.00	218.86	0.00	0.21	0.00	0.00	0.00	13.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	0.00	188.34	0.00	0.00	0.00	0.56	0.00	17.10	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	0.00	225.64	0.00	1.03	0.00	1.03	0.00	15.46	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	0.00	211.63	0.00	0.29	0.00	0.00	0.00	20.32	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	0.00	171.59	0.00	0.00	0.00	0.00	0.00	17.04	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	0.00	178.70	0.00	0.55	0.00	0.55	0.00	23.24	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	0.00	307.18	0.00	0.00	0.00	0.35	0.00	24.04	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	0.00	222.37	0.00	0.00	0.00	0.37	0.00	16.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	0.00	204.93	0.00	0.00	0.00	0.00	0.00	19.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	0.00	266.32	0.00	0.00	0.00	0.77	0.00	24.18	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	0.00	200.41	0.00	0.57	0.00	0.00	0.00	20.38	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	0.00	188.71	0.00	0.00	0.00	0.00	0.00	17.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	0.00	256.67	0.00	0.00	0.00	1.36	0.00	19.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	0.00	233.40	0.00	0.00	0.00	1.44	0.00	15.08	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	0.00	227.81	0.00	0.00	0.00	0.75	0.00	22.41	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	0.00	286.13	0.00	0.37	0.00	0.00	0.00	26.01	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	0.00	208.48	0.00	0.43	0.00	0.86	0.00	18.95	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	0.00	248.33	0.00	0.00	0.00	0.00	0.00	23.98	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	0.00	261.88	0.00	0.00	0.00	0.33	0.00	22.99	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	0.00	268.47	0.00	0.00	0.00	0.00	0.00	22.32	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	0.00	218.99	0.00	0.71	0.00	1.42	0.00	22.04	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	0.00	255.38	0.00	0.34	0.00	0.00	0.00	23.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	0.00	251.73	0.00	0.00	0.00	0.54	0.00	22.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	0.00	249.14	0.00	0.00	0.00	0.00	0.00	23.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	0.00	268.55	0.00	0.00	0.00	0.37	0.00	28.15	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	0.00	165.14	0.00	0.00	0.00	1.16	0.00	5.81	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	0.00	199.91	0.00	0.00	0.00	0.00	0.00	14.81	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	0.00	236.49	0.80	0.00	0.00	0.00	0.00	22.41	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	0.00	292.93	0.00	0.73	0.00	0.73	0.00	34.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	0.00	277.48	0.00	0.00	0.00	1.53	0.00	32.96	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	0.49	293.01	0.00	0.00	0.49	0.49	0.00	37.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	0.00	244.64	0.00	0.00	0.00	0.00	0.00	18.82	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	0.00	275.04	0.00	0.00	0.00	0.00	0.00	27.15	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	0.45	270.82	0.00	0.00	0.00	1.35	0.00	28.39	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	0.00	232.35	0.00	0.00	0.00	0.00	0.00	18.93	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	0.00	241.38	0.00	0.00	0.45	0.00	0.00	18.70	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	0.00	298.35	0.00	0.39	0.00	0.39	0.00	24.63	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	0.00	255.98	0.00	0.00	0.00	0.66	0.00	19.13	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	0.00	253.24	0.00	0.52	0.00	0.00	0.00	25.43	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	0.00	283.54	0.00	0.88	0.00	0.44	0.00	27.13	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	0.00	215.81	0.00	0.00	0.00	1.68	0.00	19.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	0.00	256.59	0.00	0.00	0.00	0.00	0.00	20.76	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	0.00	281.19	0.00	0.00	0.00	0.00	0.00	16.97	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	0.00	230.90	0.00	0.51	0.00	0.51	0.00	24.31	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	0.00	254.25	0.00	0.00	0.00	0.96	0.00	18.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	0.00	267.95	0.00	0.40	0.00	0.40	0.00	21.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	0.00	250.34	0.00	0.61	0.00	0.00	0.00	22.48	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	0.00	210.28	0.00	0.00	0.00	0.00	0.00	17.29	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	0.00	275.49	0.00	0.00	0.00	0.38	0.00	25.84	0.00	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	0.00	260.79	0.00	0.00	0.00	0.00	0.00	22.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	0.00	264.84	0.00	0.00	0.00	1.21	0.00	19.35	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	0.00	258.91	0.00	0.00	0.00	0.63	0.00	27.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	0.00	284.14	0.00	0.00	0.00	0.00	0.00	22.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	0.00	264.92	0.00	0.00	0.00	0.00	0.00	17.81	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	0.00	313.68	0.00	0.00	0.00	0.00	0.00	22.11	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	0.00	293.55	0.00	0.00	0.00	0.00	0.00	23.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	0.00	282.61	0.00	0.00	0.00	0.00	0.00	18.16	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	0.42	278.74	0.00	0.00	0.00	0.83	0.00	20.80	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	0.00	314.78	0.00	0.00	0.00	0.78	0.00	18.79	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	0.42	268.07	0.00	0.42	0.00	0.42	0.00	26.31	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	0.00	265.77	0.00	0.00	0.00	1.39	0.00	21.84	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	0.00	285.01	0.00	0.00	0.00	1.34	0.00	15.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	0.00	337.89	0.00	0.53	0.00	1.07	0.00	21.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	0.00	310.75	0.00	0.00	0.00	0.00	0.00	23.44	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	0.00	306.53	0.00	0.00	0.00	0.92	0.00	24.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	0.00	365.42	0.00	0.00	0.00	2.67	0.00	25.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	0.00	344.77	0.00	0.00	0.00	0.57	0.00	31.91	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	0.00	331.30	0.00	0.77	0.00	0.77	0.00	26.84	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	0.00	346.36	0.00	0.00	0.00	0.55	0.00	23.53	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	0.00	355.02	0.00	0.00	0.00	0.45	0.00	28.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	0.00	368.62	0.00	0.52	0.00	1.82	0.00	31.71	0.26	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	0.00	391.23	0.00	0.00	0.00	0.66	0.00	25.20	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	0.00	409.49	0.00	0.00	0.00	0.00	0.00	31.18	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	7.52	31.45	28.95	32.14	13.67	14.36	1.60	0.00	3.19	0.46
Macrophage - monocyte derived, donor2	11313-117C8	2.57	99.64	4.22	11.38	17.80	10.83	0.37	0.00	1.28	0.18
Macrophage - monocyte derived, donor3	11389-118C3	3.93	70.52	9.70	23.33	17.56	13.89	0.52	0.00	1.18	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	3.72	51.51	1.59	0.00	0.53	2.66	0.00	3.19	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	0.32	109.17	2.06	0.32	0.32	0.79	0.16	12.83	0.32	0.32
Mallassez-derived cells, donor3	11930-125I4	0.97	109.38	4.86	1.25	0.42	1.81	0.56	4.45	0.28	1.25
Mammary Epithelial Cell, donor1	11273-116H4	0.50	200.28	0.60	0.80	0.20	2.29	0.30	10.26	0.10	0.10
Mammary Epithelial Cell, donor2	11350-117G9	0.58	186.76	2.61	2.61	0.87	5.21	1.45	9.27	0.58	0.29
Mammary Epithelial Cell, donor3	11422-118F9	5.49	262.65	4.99	1.25	0.75	4.49	1.50	6.73	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	18.98	0.00	27.80	0.68	0.00	0.68	0.00	0.00	0.68	0.00
Mast cell, donor1	11563-120D6	148.48	1.08	26.17	2.49	0.00	0.32	1.51	0.00	0.87	0.11
Mast cell, donor2	11565-120D8	203.56	0.59	57.06	30.91	2.38	14.56	5.05	0.00	1.78	2.08
Mast cell, donor3	11566-120D9	215.89	2.70	51.55	58.53	3.38	25.21	13.73	0.00	2.70	0.90
Mast cell, donor4	11567-120E1	173.03	1.77	44.85	52.83	5.32	26.42	21.45	0.00	2.48	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	121.87	0.78	32.82	13.97	0.33	2.33	3.11	0.00	8.10	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	97.47	4.67	16.34	11.09	0.58	4.67	7.00	0.00	3.50	0.00
Mast cell, expanded, donor5	11939-126A4	114.49	2.06	40.73	9.52	0.46	1.61	2.87	0.00	1.72	0.00
Mast cell, expanded, donor8	11941-126A6	159.17	11.21	42.01	18.24	1.67	5.86	10.71	0.00	2.34	0.17
Melanocyte - dark, donor1	11502-119F8	95.72	1.09	2.59	2.59	0.00	0.80	0.10	0.00	0.20	0.10
Melanocyte - dark, donor2	11582-120F7	76.83	27.69	19.38	3.46	5.19	0.35	4.15	0.69	3.11	8.65
Melanocyte - dark, donor3	11663-122F7	2.75	0.43	37.23	20.65	120.03	2.90	10.07	0.07	8.26	4.56
Melanocyte - light, donor1	11274-116H5	3.06	0.00	47.01	31.26	119.89	6.82	11.05	0.00	9.64	4.70
Melanocyte - light, donor2	11351-117H1	1.36	0.68	49.82	14.33	249.10	3.41	9.55	0.00	5.46	4.09
Melanocyte - light, donor3	11423-118G1	14.74	12.14	23.42	24.28	90.19	3.47	3.47	4.34	3.47	6.94
Melanocyte, donor1 (MC+1)	12641-134G4	1.77	0.52	72.58	23.01	105.90	4.89	15.62	0.10	10.62	10.83
Melanocyte, donor2 (MC+2)	12739-135I3	4.84	0.27	37.92	12.91	50.83	2.96	12.64	0.00	9.41	4.84
Melanocyte, donor3 (MC+3)	12837-137B2	1.87	0.00	92.41	10.71	206.25	4.02	9.64	0.00	8.57	7.77
Meningeal Cells, donor1	11493-119E8	133.61	5.21	44.91	53.10	35.85	24.56	42.43	3.60	2.23	92.05
Meningeal Cells, donor2	11573-120E7	159.77	2.20	33.01	31.25	16.29	7.48	29.93	2.20	0.88	24.21
Meningeal Cells, donor3	11654-122E7	61.37	4.16	16.95	28.77	20.05	15.49	21.60	2.45	1.06	41.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	72.14	27.09	13.69	23.95	15.68	16.25	14.54	4.56	1.71	14.26
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	29.99	16.40	1.61	12.08	5.43	5.74	10.16	2.21	0.00	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	147.19	9.20	3.94	19.71	57.82	1.31	5.26	1.31	0.00	7.88
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	103.34	45.79	10.47	32.70	39.24	14.39	26.16	0.00	1.31	27.47
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	20.09	12.92	0.72	16.50	22.96	23.68	13.63	2.15	0.00	5.02
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	111.81	1.27	6.14	10.38	8.47	5.29	10.38	0.85	0.64	1.48
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	108.07	0.50	7.04	10.05	8.04	10.05	15.08	1.01	0.50	2.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	119.33	14.94	14.06	36.48	44.17	12.09	23.07	9.89	0.88	8.79
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	116.16	47.49	8.04	31.42	21.92	25.57	19.00	1.46	0.00	5.84
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	118.67	29.05	9.00	34.58	26.60	17.19	29.05	6.96	0.82	8.18
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	99.45	8.45	2.49	18.56	27.98	5.26	10.94	6.37	0.00	1.94
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	133.45	40.89	14.50	5.58	20.82	2.60	14.13	2.23	0.37	4.46
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	115.79	13.82	5.53	7.37	8.55	3.16	9.47	3.29	0.26	3.82
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	97.63	0.89	33.23	18.40	17.51	3.26	9.50	1.48	0.89	11.57
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	70.07	0.00	25.69	9.34	11.68	2.34	9.34	0.00	2.34	4.67
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	110.15	7.68	16.01	24.98	24.98	17.29	24.34	1.92	0.64	3.84
Mesenchymal stem cells - adipose, donor0	11217-116B2	15.95	15.24	2.84	26.94	33.67	16.30	11.34	1.42	0.35	4.61
Mesenchymal stem cells - hepatic, donor0	11218-116B3	86.62	9.07	3.75	8.13	7.51	5.00	7.19	0.94	0.31	1.56
Mesenchymal stem cells - umbilical, donor0	11214-116A8	45.72	5.81	10.89	13.06	17.42	8.71	12.34	1.45	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	26.78	34.47	1.59	2.92	7.69	0.27	0.00	1.86	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	16.52	41.54	0.50	1.50	3.00	0.00	0.00	1.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	13.08	69.81	0.51	2.38	5.85	0.36	0.72	1.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	33.76	47.26	21.61	17.55	5.40	13.50	2.70	0.00	1.35	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	39.40	67.97	25.86	24.63	14.53	15.76	1.48	0.00	2.46	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	17.37	98.64	12.37	21.20	16.49	18.85	0.88	0.00	3.53	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	31.11	55.31	6.91	38.03	6.91	13.83	0.00	0.00	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	28.21	39.67	19.84	16.43	11.78	9.30	0.62	0.00	1.55	1.24
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	10.58	81.73	8.09	12.24	14.31	13.69	0.41	0.00	2.49	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	27.79	25.48	0.00	44.00	0.00	16.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	22.27	63.32	20.02	25.03	17.27	14.26	2.25	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	19.08	97.75	12.10	14.90	10.24	20.48	0.00	0.00	6.52	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	19.47	19.47	19.47	0.00	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	23.78	62.79	17.27	17.68	15.65	10.57	1.42	0.00	2.44	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	15.05	96.61	13.86	11.09	15.84	15.44	1.19	0.00	2.38	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	34.21	0.00	42.76	0.00	25.65	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	32.74	27.43	23.01	11.50	14.16	7.08	0.88	0.00	2.65	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	12.92	96.12	8.74	15.58	15.96	11.40	0.76	0.00	2.66	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	28.95	40.79	11.84	22.37	7.90	15.79	1.32	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	27.80	39.05	19.95	11.67	15.70	11.25	2.33	0.00	2.97	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	9.21	69.06	15.65	10.13	8.29	12.89	0.00	0.00	2.76	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	215.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	29.21	39.64	14.60	11.62	9.84	8.05	1.19	0.00	2.38	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	13.41	90.54	6.71	20.12	6.71	16.77	0.00	0.00	1.68	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	33.95	0.00	0.00	0.00	67.90	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	21.08	42.40	14.55	10.79	13.05	9.03	1.25	0.00	2.51	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	13.07	68.21	9.98	10.70	12.12	14.26	0.24	0.00	4.28	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	11.06	33.17	10.50	12.72	4.42	25.43	1.11	0.00	1.11	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	19.34	39.14	15.66	17.04	12.43	12.43	0.46	0.00	0.69	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	11.15	92.34	9.25	10.31	17.25	15.14	1.89	0.00	1.89	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	15.29	49.12	11.41	16.10	8.56	13.25	0.20	0.00	0.82	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	16.52	32.61	17.59	13.09	13.09	7.94	1.29	0.00	1.72	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	9.11	72.02	4.67	10.23	10.45	12.67	0.89	0.00	1.56	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	41.27	10.32	61.91	0.00	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	10.51	42.93	10.51	18.18	8.10	13.36	0.88	0.00	1.31	0.88
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	12.17	57.29	5.07	9.13	7.60	10.14	0.00	0.00	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	31.48	6.63	36.45	6.63	18.23	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	15.22	36.42	15.76	19.03	7.07	15.22	0.54	0.00	1.63	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	8.82	78.81	6.76	12.65	10.29	15.59	0.59	0.29	0.88	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	8.72	41.43	5.45	28.35	3.27	20.72	0.00	0.00	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	7.69	24.99	10.57	15.86	5.29	14.42	1.92	0.00	2.40	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	6.80	92.85	6.00	10.81	10.01	18.01	1.20	0.40	1.60	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	8.23	53.48	5.48	27.42	10.97	35.65	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	4.00	48.06	8.51	14.52	10.51	12.51	0.00	1.00	1.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	107.79	0.00	26.95	0.00	26.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	57.08	0.00	18.35	4.08	20.39	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	1.31	41.60	7.44	13.58	8.32	10.07	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	6.62	108.16	5.52	23.18	6.62	18.76	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	1.92	53.15	3.20	32.02	4.48	17.29	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	3.47	57.27	3.97	15.37	16.61	13.64	0.25	0.00	0.50	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	2.78	66.81	1.39	23.66	6.96	20.18	0.00	0.00	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	59.67	0.00	48.62	4.42	22.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	2.74	36.24	1.03	11.97	10.94	9.57	0.34	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	3.06	80.96	2.19	24.94	9.63	16.63	1.31	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	3.55	32.67	1.42	21.31	1.07	11.01	0.36	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	2.81	37.03	1.40	14.03	8.70	8.98	0.28	0.00	0.56	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	1.66	84.37	2.91	17.04	15.38	12.47	1.25	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	1.75	22.14	0.00	16.90	1.17	5.83	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	2.11	36.80	1.51	10.56	6.94	4.22	0.60	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	1.25	86.40	2.50	16.28	11.27	12.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	64.97	0.00	28.88	14.44	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	1.85	20.32	0.00	10.16	4.62	7.39	1.85	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	0.57	67.16	2.28	25.04	12.52	19.35	0.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	2.63	15.48	2.35	10.92	4.15	5.11	0.14	0.00	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	1.04	17.62	3.11	10.63	7.26	5.44	0.26	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	0.43	50.62	1.72	18.45	8.58	18.45	0.86	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	2.54	14.61	1.27	12.70	3.18	3.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	1.60	17.35	4.27	13.34	4.00	5.60	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	4.79	45.20	6.29	20.06	10.48	18.86	0.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	4.10	7.35	4.94	9.04	3.67	3.81	0.28	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	2.23	7.64	4.14	10.19	7.64	4.14	0.64	0.00	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	0.66	41.79	2.43	15.48	10.84	11.72	0.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	2.65	11.00	3.41	14.79	3.41	6.45	0.00	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	2.84	9.66	5.40	13.35	4.26	5.40	0.85	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	1.47	34.41	2.95	14.75	6.39	11.80	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	4.56	14.34	5.21	22.16	0.65	11.08	0.00	0.00	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	3.53	16.17	9.41	17.64	5.00	4.12	0.29	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	4.04	35.75	4.90	15.57	8.36	14.42	0.58	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	9.48	21.02	11.95	11.13	6.18	6.18	0.82	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	6.55	20.55	8.93	25.91	8.34	5.96	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	0.00	22.60	3.77	3.77	3.77	7.53	0.00	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	14.26	21.39	42.77	17.82	1.78	1.78	1.78	0.00	7.13	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	36.80	9.53	48.30	22.67	8.87	10.51	0.99	0.00	3.61	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	7.36	49.44	23.14	13.68	9.47	11.57	1.05	0.00	2.10	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	20.76	11.07	52.19	16.01	13.64	7.31	1.38	0.00	9.29	1.78
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	13.97	54.02	59.60	34.46	23.28	14.90	1.86	0.00	6.52	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	27.79	25.91	62.71	20.28	19.15	14.65	1.50	0.00	5.26	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	16.78	51.14	43.68	18.11	15.18	11.19	1.33	0.00	7.46	1.07
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	9.61	8.14	22.51	18.77	9.39	6.11	0.45	0.00	3.28	1.02
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	25.79	19.89	49.36	14.73	11.79	8.84	1.47	0.00	1.47	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	37.74	7.33	45.44	20.89	9.89	7.69	1.83	0.00	2.56	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	17.11	45.11	31.11	21.78	15.56	20.22	3.11	0.00	3.11	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	5.34	5.34	6.41	9.09	5.88	3.21	0.00	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	19.32	38.64	23.18	3.86	15.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	42.42	10.10	56.56	23.23	9.09	8.08	0.00	0.00	5.05	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	5.06	46.80	15.60	12.23	8.01	5.90	1.26	0.00	2.53	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	4.09	0.00	1.36	1.36	1.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	4.45	1.27	0.64	0.00	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.81	0.00	0.81	0.00	0.00	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	10.57	1.51	3.02	3.02	3.02	0.00	0.00	4.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	5.71	0.00	11.42	5.71	17.13	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	0.00	16.31	26.10	13.05	3.26	13.05	0.00	0.00	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	9.50	19.01	0.00	19.01	4.75	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	12.55	12.55	12.55	0.00	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	17.45	2.37	3.23	29.08	17.02	19.39	11.42	2.80	0.00	4.09
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	62.19	1.57	2.09	24.04	26.65	8.88	10.97	0.52	0.52	2.61
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	257.65	10.68	4.00	8.68	2.00	4.67	9.34	1.33	0.00	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	245.00	15.03	6.26	7.51	0.00	2.92	2.09	0.83	0.00	1.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	226.65	15.02	5.51	24.72	2.09	5.51	5.13	3.61	0.19	2.09
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	335.13	7.98	9.58	14.36	0.00	1.60	1.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	282.86	12.24	4.08	3.40	0.00	0.00	1.36	0.00	0.68	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	73.51	14.70	3.68	34.92	3.68	5.51	7.35	0.00	0.00	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	251.12	2.93	5.02	5.02	3.35	1.67	7.12	0.00	0.42	1.67
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	271.49	16.97	4.18	9.99	0.46	3.25	2.09	2.56	0.23	6.51
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	453.71	10.81	10.27	2.97	0.81	1.35	5.67	0.27	0.54	12.43
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	289.29	4.84	11.56	8.62	0.21	1.26	0.84	2.52	0.00	9.88
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	77.94	33.40	0.00	11.13	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	298.31	7.45	9.93	6.95	1.99	2.98	7.94	1.99	0.00	12.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	175.66	2.98	2.71	9.20	3.52	0.81	8.12	0.54	0.00	2.98
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	244.36	10.88	2.95	7.03	0.23	1.81	2.95	0.91	0.23	4.31
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	328.89	6.04	5.06	1.63	0.98	0.65	3.10	0.33	0.65	6.70
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	253.52	5.83	5.29	4.01	1.46	0.73	0.18	1.82	0.36	8.75
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	358.57	8.49	4.77	3.18	0.00	1.59	3.71	2.12	0.00	3.71
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	343.37	10.21	6.00	3.60	4.20	0.60	4.20	0.60	0.00	3.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	120.77	0.98	2.30	7.88	6.56	1.64	7.22	0.66	0.00	1.97
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	256.30	8.62	1.79	3.58	0.00	0.49	3.25	1.14	0.16	1.79
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	285.74	3.35	6.70	2.82	0.71	0.18	0.71	1.94	0.18	9.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	390.29	6.33	4.92	3.52	0.70	0.70	4.22	1.41	0.70	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	296.05	5.52	2.30	1.84	3.68	0.00	9.19	1.38	0.00	3.68
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	266.39	1.61	1.61	5.46	4.50	0.32	12.53	0.32	0.64	3.21
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	172.44	8.97	1.03	8.62	0.34	1.38	3.79	2.07	0.00	2.07
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	184.58	5.06	7.59	2.53	2.53	0.00	0.00	2.53	0.00	12.64
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	265.78	2.01	5.12	4.23	0.45	0.00	0.67	1.11	0.22	3.79
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	370.47	6.35	2.12	2.96	0.00	1.27	2.96	0.00	0.00	2.96
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	263.93	4.75	4.27	4.98	1.90	0.24	2.85	0.47	0.24	5.46
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	253.26	4.72	1.29	3.86	3.00	0.43	11.59	0.86	0.00	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	90.28	9.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	348.22	5.00	4.33	3.00	1.00	0.00	2.33	1.33	0.33	1.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	241.21	2.71	2.25	4.06	0.00	0.90	0.00	1.35	0.00	2.71
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	209.11	3.97	0.79	1.98	0.00	0.00	2.38	1.19	0.40	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	358.46	3.71	4.64	13.00	1.86	1.86	8.36	0.00	0.93	3.71
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	155.51	1.14	0.38	7.57	2.27	0.76	9.08	0.76	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	240.18	10.43	1.96	2.93	0.98	1.96	4.24	2.28	0.00	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	348.19	3.92	2.18	0.87	1.74	0.44	3.92	0.44	0.00	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	240.16	2.71	4.07	3.62	0.00	0.45	0.45	3.17	0.45	1.81
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	279.57	4.41	2.65	2.65	0.88	0.88	7.94	0.00	0.00	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	330.43	1.99	3.99	2.66	1.99	0.00	5.98	0.66	0.00	3.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	235.62	0.99	0.99	4.96	5.95	1.49	10.42	0.00	0.00	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	245.77	9.95	2.68	1.53	0.00	1.15	6.13	2.68	0.38	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	195.68	3.93	1.21	6.05	1.21	0.30	4.54	0.60	0.00	2.12
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	132.84	1.33	3.98	5.75	0.22	0.66	1.77	4.64	0.00	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	270.38	4.07	0.00	2.03	0.00	2.03	6.78	1.36	0.68	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	117.52	0.00	0.00	10.22	0.00	0.00	0.00	0.00	0.00	15.33
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	195.71	1.22	2.44	1.83	1.83	1.22	16.46	0.00	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	187.58	8.50	1.57	4.72	0.63	2.20	4.72	4.72	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	383.16	4.24	2.12	1.51	1.21	0.00	5.45	0.30	0.00	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	178.80	1.58	0.79	0.79	0.00	0.79	0.79	2.37	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	121.30	6.80	3.40	10.20	0.00	1.13	2.27	0.00	0.00	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	80.93	5.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	36.03	3.11	1.12	14.91	10.56	11.68	6.21	2.48	0.12	0.62
Myoblast, donor2	11322-117D8	123.90	29.92	0.77	22.25	10.74	12.66	8.63	7.29	0.38	1.15
Myoblast, donor3	11398-118D3	60.54	5.04	3.03	13.45	6.56	8.07	5.38	5.72	0.00	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	263.70	0.00	150.75	1.31	0.00	0.29	0.00	0.00	91.06	0.88
Natural Killer Cells, donor1	11230-116C6	97.18	0.31	177.74	0.00	0.00	0.92	0.00	0.00	2.46	0.00
Natural Killer Cells, donor2	11311-117C6	118.81	0.30	179.43	0.60	0.00	0.00	0.00	0.00	3.02	0.00
Natural Killer Cells, donor3	11387-118C1	103.44	0.37	161.78	0.55	0.00	1.47	0.00	0.00	2.58	0.00
Neural stem cells, donor1	11275-116H6	260.59	1.09	156.06	0.36	0.36	0.36	1.09	0.00	27.95	80.57
Neural stem cells, donor2	11352-117H2	154.05	0.00	159.83	0.00	0.00	0.00	0.00	0.00	11.55	57.77
Neurons, donor1	11494-119E9	39.83	0.00	29.59	0.00	0.00	0.00	0.00	0.00	3.41	12.52
Neurons, donor2	11574-120E8	25.32	1.32	36.11	0.66	0.44	0.00	1.10	0.22	2.86	16.07
Neurons, donor3	11655-122E8	35.35	0.00	20.55	0.00	0.00	0.00	0.00	0.00	0.82	6.58
Neutrophils, donor1	11233-116C9	56.61	0.00	29.70	0.00	0.00	4.64	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	60.88	0.00	60.88	0.00	0.00	0.00	0.00	0.00	2.90	0.00
Neutrophils, donor3	11390-118C4	100.79	0.00	17.71	0.00	0.00	3.05	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	141.18	7.84	10.92	10.21	29.92	2.26	4.99	4.99	1.07	17.69
Nucleus Pulposus Cell, donor2	11409-118E5	152.06	12.70	8.79	6.84	23.44	3.26	4.23	3.58	0.98	10.09
Nucleus Pulposus Cell, donor3	11462-119B4	106.49	8.42	8.62	12.63	21.26	3.61	9.43	1.40	0.60	10.23
Olfactory epithelial cells, donor1	11933-125I7	213.64	2.20	3.44	15.00	8.67	8.40	11.70	0.55	0.00	2.75
Olfactory epithelial cells, donor2	11934-125I8	237.53	0.87	2.75	17.51	11.72	16.07	9.99	0.58	0.43	2.61
Olfactory epithelial cells, donor3	11935-125I9	125.88	0.45	1.36	12.49	8.06	6.92	7.04	0.23	0.00	0.57
Olfactory epithelial cells, donor4	11936-126A1	319.17	1.17	1.95	25.42	6.92	12.66	13.25	0.29	0.39	1.66
Oligodendrocyte - precursors, donor1	11496-119F2	24.67	109.53	1.81	3.61	0.00	3.01	2.41	3.61	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	242.90	11.70	1.91	19.78	27.65	4.47	14.04	5.74	0.00	1.91
Osteoblast - differentiated, donor2	11353-117H3	78.87	11.43	0.00	8.00	24.01	2.29	9.14	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	68.28	4.34	4.97	5.59	10.55	3.72	1.86	2.48	0.62	1.86
Osteoblast, donor1	11277-116H8	120.98	22.48	13.49	36.74	47.30	14.07	24.43	11.53	0.00	15.63
Osteoblast, donor2	11354-117H4	96.92	16.15	4.92	29.50	25.28	16.15	18.96	2.81	0.00	6.32
Osteoblast, donor3	11426-118G4	136.50	23.99	6.75	28.61	19.02	16.17	18.66	10.31	0.18	4.98
Pancreatic stromal cells, donor1	11249-116E7	110.69	6.15	6.82	18.28	32.85	4.80	6.82	0.42	0.34	5.31
Pericytes, donor1	11491-119E6	345.26	20.36	123.28	29.37	34.60	14.91	21.92	3.78	33.49	294.30
Pericytes, donor2	11571-120E5	431.91	5.66	81.72	10.41	16.30	2.26	17.43	1.36	9.96	88.06
Pericytes, donor3	11652-122E5	132.45	40.89	5.09	27.26	16.48	16.68	18.51	3.46	1.22	11.39
Perineurial Cells, donor1	11499-119F5	60.92	3.50	5.88	19.33	10.74	8.36	11.64	0.68	0.34	11.30
Perineurial Cells, donor2	11579-120F4	76.28	29.72	22.45	5.24	8.83	1.38	4.42	1.10	2.48	11.13
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	100.40	0.64	198.26	5.10	0.32	1.91	0.32	0.00	15.62	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	83.74	0.24	126.59	1.47	0.24	3.18	0.00	0.00	5.88	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	103.92	1.04	178.46	3.62	0.39	6.47	0.39	0.00	6.73	0.52
Placental Epithelial Cells, donor1	11278-116H9	5.26	8.37	14.59	9.81	7.65	23.44	7.65	2.39	0.48	6.94
Placental Epithelial Cells, donor2	11355-117H5	31.05	13.31	9.98	8.87	5.54	14.42	6.65	11.09	0.00	13.31
Placental Epithelial Cells, donor3	11427-118G5	59.09	10.41	29.65	10.21	8.44	18.06	10.21	5.89	0.59	17.87
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	32.59	1.27	0.95	9.18	5.38	2.22	3.16	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	20.82	1.69	0.19	4.88	9.00	2.63	3.94	0.00	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	20.10	1.44	0.00	6.66	12.53	3.00	7.31	0.13	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	35.57	1.58	0.45	8.56	9.91	2.48	5.18	0.23	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	42.94	1.81	0.21	6.50	10.12	3.94	5.65	0.00	0.00	0.11
Preadipocyte - omental, donor2	11329-117E6	24.88	2.62	0.00	6.55	9.60	3.06	5.67	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	46.13	4.73	0.00	6.30	5.73	3.01	6.16	0.14	0.00	0.00
Preadipocyte - perirenal, donor1	11469-119C2	71.85	1.97	0.98	9.84	4.92	5.91	4.92	0.98	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	105.96	17.20	5.22	23.96	45.15	8.60	21.81	1.23	1.23	6.76
Preadipocyte - subcutaneous, donor2	11356-117H6	71.19	7.97	3.72	16.47	44.45	12.22	13.99	0.89	1.59	4.25
Preadipocyte - subcutaneous, donor3	11428-118G6	100.30	5.79	2.72	16.01	28.95	6.64	15.16	0.00	0.34	4.43
Preadipocyte - visceral, donor1	11280-116I2	91.47	5.87	8.76	26.08	36.33	13.79	15.00	0.65	0.65	15.74
Preadipocyte - visceral, donor2	11357-117H7	196.50	5.52	1.38	11.04	20.71	6.90	6.90	0.00	0.00	5.98
Preadipocyte - visceral, donor3	11429-118G7	80.35	8.57	3.87	22.26	28.00	16.09	17.03	0.42	0.42	6.79
Prostate Epithelial Cells (polarized), donor1	11253-116F2	0.15	170.31	12.52	0.30	0.00	0.91	0.00	0.00	3.92	0.75
Prostate Epithelial Cells, donor2	11331-117E8	1.35	161.95	4.60	0.14	0.00	0.27	0.27	12.46	0.27	1.49
Prostate Epithelial Cells, donor3	11404-118D9	0.06	84.32	0.06	0.43	0.00	0.43	0.12	3.80	0.18	0.00
Prostate Stromal Cells, donor1	11254-116F3	65.95	49.66	4.33	17.88	8.43	7.97	7.06	1.37	0.46	2.39
Prostate Stromal Cells, donor2	11332-117E9	116.01	26.72	6.63	16.32	15.24	8.25	9.32	0.36	2.15	4.84
Prostate Stromal Cells, donor3	11405-118E1	157.98	10.64	7.72	11.16	15.75	3.02	5.32	0.52	0.52	3.55
Renal Cortical Epithelial Cells, donor1	11516-119H4	25.91	183.59	34.67	2.19	0.73	2.92	0.73	18.98	0.73	4.01
Renal Cortical Epithelial Cells, donor2	11596-120H3	16.36	99.67	12.48	1.52	0.28	2.15	0.00	12.27	1.66	1.59
Renal Epithelial Cells, donor1	11517-119H5	45.65	329.70	64.42	4.57	2.54	2.54	0.00	23.33	7.10	11.16
Renal Epithelial Cells, donor2	11597-120H4	48.37	175.70	32.01	2.85	0.71	6.40	0.00	31.30	2.85	7.82
Renal Epithelial Cells, donor3	11678-122H4	29.54	89.99	13.23	1.27	0.11	1.48	0.21	28.05	0.74	1.27
Renal Glomerular Endothelial Cells, donor1	11514-119H2	89.87	6.13	17.02	6.81	1.36	2.72	6.13	0.00	0.68	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	40.43	8.36	14.15	16.44	0.67	12.94	5.26	0.54	0.54	1.35
Renal Glomerular Endothelial Cells, donor3	11675-122H1	43.74	58.83	23.09	9.55	3.55	6.44	1.55	9.55	0.67	3.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	72.53	13.97	15.97	6.65	2.00	0.67	2.66	1.33	0.00	2.66
Renal Mesangial Cells, donor1	11518-119H6	73.73	269.39	53.48	11.00	6.16	6.38	4.18	27.95	4.62	24.21
Renal Mesangial Cells, donor2	11598-120H5	57.06	188.10	47.65	7.52	3.76	6.27	1.25	33.86	3.13	10.66
Renal Mesangial Cells, donor3	11679-122H5	48.27	272.70	43.00	7.21	3.61	1.66	3.05	18.59	4.44	14.70
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	16.37	250.98	9.66	1.88	0.00	2.42	0.00	9.13	1.07	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	22.35	153.50	5.90	2.11	0.00	2.11	0.00	8.01	0.84	1.69
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	36.26	257.84	35.10	3.09	0.19	5.59	0.39	15.62	1.74	9.64
Retinal Pigment Epithelial Cells, donor0	11215-116A9	31.89	196.02	17.63	1.04	0.26	0.00	0.26	2.33	0.26	2.85
Retinal Pigment Epithelial Cells, donor1	11528-119I7	17.05	223.70	16.49	1.14	0.57	0.28	0.28	4.26	0.00	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	33.96	194.50	11.32	7.20	3.09	6.17	1.03	6.17	1.03	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	5.02	100.86	3.01	0.50	1.00	1.25	0.00	1.00	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	26.06	37.95	5.61	8.15	1.20	2.27	2.27	5.08	0.00	3.88
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	17.87	78.62	0.89	92.91	5.36	41.10	41.10	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	14.86	69.90	0.00	98.52	12.66	39.08	44.03	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	25.52	40.60	0.00	111.37	6.38	44.66	37.12	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	35.63	47.59	0.13	72.81	7.93	32.90	48.11	8.84	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	48.26	47.87	0.20	50.05	11.62	29.49	34.06	9.24	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	41.38	54.77	0.11	50.30	9.59	24.32	37.03	8.25	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	33.62	55.82	0.25	81.00	11.41	39.57	46.52	10.54	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	45.22	54.78	0.47	54.08	12.70	28.67	35.43	5.59	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	62.87	64.72	0.00	55.01	12.71	40.22	38.83	6.93	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	44.36	47.23	0.14	66.40	7.80	32.04	43.26	6.85	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	50.22	46.44	0.00	59.45	11.35	29.04	35.40	5.45	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	40.32	55.55	0.36	62.18	8.78	21.68	36.02	6.81	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	41.17	57.38	0.14	69.15	10.19	31.13	50.07	8.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	43.68	44.96	0.32	55.16	11.05	29.62	35.95	7.51	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	59.08	53.33	0.22	64.39	11.73	30.76	44.92	6.64	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	40.91	52.76	1.34	77.62	8.79	36.51	44.74	6.31	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	47.79	44.90	0.47	58.04	10.25	33.35	35.96	6.80	0.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	46.98	67.65	0.38	50.73	13.34	29.69	42.47	7.70	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	51.49	47.91	0.00	74.32	8.10	40.87	48.04	6.24	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	48.57	50.91	0.39	57.33	10.51	34.46	35.53	8.57	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	49.46	61.11	0.57	58.24	12.60	37.05	49.08	8.02	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	43.04	58.20	0.21	68.24	9.18	32.25	43.89	8.97	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	44.85	58.02	0.28	54.38	9.53	29.71	39.80	6.17	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	49.22	48.54	0.51	68.53	11.79	32.47	40.16	6.67	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	44.85	51.96	0.18	75.30	7.66	42.12	44.85	8.02	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	43.41	46.23	0.49	53.84	12.14	35.44	36.91	9.07	0.00	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	55.47	64.07	0.13	65.41	15.18	37.48	45.27	9.54	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	35.85	60.15	0.24	67.70	11.79	33.73	47.41	10.85	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	43.25	54.17	0.40	52.98	12.50	28.97	38.10	7.54	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	57.53	54.72	0.23	68.52	14.26	39.75	59.40	7.25	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	31.52	46.45	0.21	64.07	11.82	29.65	46.03	7.67	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	39.82	57.74	0.22	55.97	11.95	47.12	48.00	9.51	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	50.97	50.55	0.21	61.83	12.32	39.69	48.04	7.94	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	42.13	49.12	0.40	67.97	12.52	38.89	54.37	11.71	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	45.81	43.94	0.17	79.02	10.22	42.40	43.94	8.86	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	48.58	43.96	0.58	62.47	10.60	39.72	55.33	9.06	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	30.09	38.69	0.34	67.92	16.16	42.81	56.05	11.69	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	45.40	34.57	0.41	68.31	13.31	41.97	44.99	6.86	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	36.77	35.13	0.00	61.73	17.73	44.00	57.30	7.72	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	48.91	43.29	0.17	71.07	10.91	33.75	56.75	3.41	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	54.74	47.79	0.74	64.21	16.13	33.88	47.20	6.51	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	60.24	43.18	0.80	65.30	9.86	35.18	51.71	4.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	42.72	46.87	0.55	76.18	8.02	32.08	56.55	1.80	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	77.62	39.05	0.24	64.76	9.52	19.76	40.95	2.38	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	124.96	70.14	0.40	67.31	10.88	26.60	51.59	5.44	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	71.38	42.76	0.38	61.97	8.29	25.99	60.93	2.26	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	42.62	52.40	0.70	61.14	15.72	43.67	54.85	1.75	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	44.12	47.75	0.00	66.18	13.30	35.96	49.56	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	66.09	51.65	0.12	68.05	9.55	31.21	59.24	3.92	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	40.61	74.38	0.29	92.28	15.57	50.80	73.94	2.62	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	52.93	63.88	0.00	84.57	9.73	30.42	51.72	2.43	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	61.49	52.44	0.90	75.65	9.64	28.63	56.96	1.81	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	38.45	84.14	0.45	62.43	13.57	42.52	57.23	2.49	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	49.42	109.33	0.00	70.69	8.69	49.42	50.62	2.10	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	22.91	76.87	0.12	67.89	13.46	34.83	54.43	1.77	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	37.14	100.96	1.07	64.46	11.53	44.61	62.11	2.13	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	51.68	91.35	1.80	75.72	10.82	42.07	54.69	1.80	0.00	0.00
Schwann Cells, donor1	11498-119F4	99.11	14.11	29.34	34.79	31.41	19.18	29.90	3.20	0.56	11.66
Schwann Cells, donor2	11578-120F3	23.82	3.40	0.00	30.62	20.41	13.61	13.61	3.40	0.00	3.40
Schwann Cells, donor3	11659-122F3	93.55	10.08	17.31	13.80	13.80	5.04	11.61	3.29	0.00	7.89
Sebocyte, donor1	11220-116B5	4.38	265.67	4.93	3.83	6.57	3.83	1.10	13.15	0.00	0.55
Sebocyte, donor2	11301-117B5	3.68	174.63	1.38	0.46	2.76	1.84	0.92	3.22	0.00	0.46
Sebocyte, donor3	11378-118B1	38.96	53.59	2.06	6.39	12.57	2.68	4.74	1.44	0.82	2.06
Sertoli Cells, donor1	11255-116F4	76.20	6.63	0.00	21.54	16.57	8.28	11.60	0.00	0.00	4.97
Sertoli Cells, donor2	11333-117F1	189.23	0.00	2.82	2.82	16.95	8.47	11.30	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	144.64	1.94	15.66	8.09	14.43	1.67	6.60	0.26	1.76	29.38
Skeletal Muscle Cells, donor2	11358-117H8	263.12	0.00	3.61	3.61	9.40	0.00	2.17	0.72	1.45	7.95
Skeletal Muscle Cells, donor3	11430-118G8	326.05	7.52	15.05	20.06	34.28	5.85	25.92	2.51	0.84	35.11
Skeletal Muscle Cells, donor4	11451-119A2	119.23	11.94	9.11	21.84	24.66	8.64	19.48	0.47	0.31	11.78
Skeletal Muscle Cells, donor5	11455-119A6	138.69	11.00	7.28	13.97	24.67	6.24	16.05	1.34	0.45	9.07
Skeletal Muscle Cells, donor6	11459-119B1	126.66	3.69	10.16	16.93	25.70	9.23	16.01	0.92	0.62	9.54
Skeletal Muscle Satellite Cells, donor1	11240-116D7	82.28	1.26	11.97	11.34	34.27	2.02	8.57	2.02	0.13	13.73
Skeletal Muscle Satellite Cells, donor2	11321-117D7	187.49	3.71	7.56	10.42	27.25	1.00	8.70	1.14	1.14	9.70
Skeletal Muscle Satellite Cells, donor3	11397-118D2	121.63	5.36	15.28	14.68	32.24	7.44	16.37	0.89	0.79	16.47
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	240.46	1.77	15.42	2.11	7.92	0.42	5.81	2.11	2.36	11.88
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	175.87	1.45	10.86	19.54	22.44	12.30	7.96	0.00	0.72	15.92
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	270.66	0.69	23.39	10.73	19.26	2.89	20.78	0.96	1.24	21.47
Skin - palm, donor1	10286-104F7	83.27	59.09	2.69	37.61	5.37	16.12	5.37	0.00	0.00	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	0.29	137.53	1.73	0.00	0.00	0.14	0.00	6.34	0.00	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	0.00	296.08	0.82	0.00	0.00	0.00	0.00	13.09	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	0.65	186.17	1.69	0.00	0.00	0.13	0.00	7.53	0.13	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	0.00	156.80	0.00	0.00	0.14	0.00	0.00	9.04	0.00	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	0.28	139.95	0.14	0.14	0.00	0.14	0.00	5.91	0.00	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	0.63	283.13	1.06	0.00	0.00	0.21	0.00	15.44	0.85	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	0.22	133.19	0.22	0.00	0.07	0.07	0.00	6.75	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	153.98	9.26	1.85	16.66	11.11	7.71	4.94	0.31	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	68.48	7.78	0.67	7.11	8.45	2.89	7.78	1.11	0.00	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	155.77	8.23	2.35	14.11	19.40	4.70	5.29	1.76	0.59	2.94
Smooth Muscle Cells - Aortic, donor1	11283-116I5	49.28	10.61	2.21	13.48	19.01	5.75	11.49	1.33	1.10	2.21
Smooth Muscle Cells - Aortic, donor2	11360-117I1	136.25	7.88	2.76	24.41	14.18	11.03	13.78	0.39	0.79	3.54
Smooth Muscle Cells - Aortic, donor3	11432-118H1	165.33	7.73	3.86	18.54	23.18	5.41	7.73	0.77	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	122.09	5.00	12.01	9.01	5.00	2.00	0.00	0.00	0.00	6.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	88.90	2.13	1.73	16.77	15.44	4.52	9.45	0.13	0.00	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	147.18	1.99	3.77	17.07	24.16	7.31	10.86	0.44	0.66	18.62
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	45.83	2.94	1.02	19.97	5.51	9.47	7.17	0.38	0.13	0.90
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	69.68	2.28	14.98	8.14	7.81	1.63	8.14	0.33	1.30	17.26
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	65.27	22.74	9.45	17.42	15.36	2.66	15.36	4.43	0.89	10.34
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	31.89	56.23	3.27	7.12	17.08	2.85	5.98	1.42	0.14	1.42
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	199.11	77.92	5.86	15.94	21.31	3.25	10.41	0.81	0.65	3.90
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	228.02	18.27	5.18	8.83	17.96	1.83	7.61	0.00	0.30	10.66
Smooth Muscle Cells - Carotid, donor1	11285-116I7	287.92	4.04	4.04	19.19	27.02	3.79	9.09	1.52	0.51	18.18
Smooth Muscle Cells - Carotid, donor2	11362-117I3	97.93	0.00	0.00	6.12	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	123.98	28.13	2.38	24.32	10.97	8.11	11.92	0.00	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	68.13	11.50	3.98	7.96	10.62	0.88	5.31	0.88	0.00	1.47
Smooth Muscle Cells - Colonic, donor2	11320-117D6	82.65	16.79	4.30	8.82	15.93	1.08	6.46	2.15	0.00	2.58
Smooth Muscle Cells - Colonic, donor3	11396-118D1	80.92	22.46	7.14	9.03	12.39	1.99	10.08	1.78	0.21	2.73
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	136.43	8.04	3.25	20.11	15.93	9.28	14.54	0.77	0.00	6.19
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	184.32	7.55	2.16	15.09	4.31	4.31	14.01	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	97.13	8.37	3.29	15.54	10.46	2.99	11.36	1.79	0.30	3.89
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	162.51	60.43	16.05	11.95	19.80	4.10	12.63	0.68	0.34	7.51
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	135.93	12.17	3.46	6.75	9.58	1.73	4.87	0.55	0.63	1.81
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	180.45	2.72	0.40	11.78	10.67	8.25	6.04	0.10	0.00	1.11
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	78.96	10.01	1.37	7.51	12.74	4.10	9.33	0.46	0.00	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	128.61	10.87	3.62	23.55	20.53	7.85	11.47	0.60	0.00	1.81
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	49.01	33.65	12.98	15.90	8.48	7.15	12.72	0.26	1.06	5.83
Smooth Muscle Cells - Prostate, donor1	11257-116F6	197.74	13.45	7.59	21.70	15.18	7.59	9.72	0.27	1.07	8.92
Smooth Muscle Cells - Prostate, donor2	11335-117F3	148.26	35.69	6.51	10.14	9.77	2.88	6.14	0.00	1.00	2.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	67.73	1.52	4.31	11.92	24.10	3.04	4.06	0.00	0.76	14.97
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	213.65	7.84	6.63	22.16	17.19	5.73	15.83	0.15	0.75	7.39
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	198.04	4.50	6.00	15.75	27.01	0.75	9.00	0.00	0.75	4.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	45.23	1.29	9.05	1.29	23.26	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	202.77	2.79	6.51	19.07	20.46	5.58	17.67	0.93	0.47	3.72
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	140.36	5.55	0.50	11.11	3.53	6.06	5.05	0.00	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	127.55	2.51	0.31	13.48	8.78	6.58	5.01	0.31	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	151.92	19.76	3.83	15.63	21.83	3.24	10.91	0.29	0.88	3.24
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	104.05	30.91	8.41	16.41	16.83	3.83	12.50	0.50	0.42	9.16
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	208.35	10.28	5.14	5.61	10.28	1.40	6.54	0.47	0.93	4.67
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	60.45	1.73	3.60	23.89	10.36	11.37	11.66	1.58	0.86	1.73
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	98.16	21.16	10.71	21.93	16.32	9.69	15.55	2.80	1.02	4.08
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	165.09	10.34	7.71	17.11	13.73	6.21	18.99	1.69	0.56	4.32
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	37.45	10.06	11.74	24.18	23.76	7.69	16.49	1.96	0.42	3.91
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	31.92	7.71	6.20	17.85	21.87	7.37	9.64	1.42	0.34	2.26
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	46.19	10.00	3.33	20.95	14.29	10.48	15.71	1.43	0.00	1.43
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	59.70	3.43	4.40	20.06	12.72	9.30	8.56	1.96	0.49	2.94
Smooth Muscle Cells - Uterine, donor1	11258-116F7	176.76	11.49	6.19	13.92	14.58	7.73	16.79	0.00	0.66	9.06
Smooth Muscle Cells - Uterine, donor3	11466-119B8	122.88	3.51	0.88	19.31	13.17	10.53	7.31	0.00	0.88	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	53.84	0.19	2.92	6.22	19.63	0.00	2.33	0.19	0.00	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	120.33	1.32	0.26	5.02	8.46	1.85	4.23	0.00	0.53	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	73.27	0.37	2.98	7.44	17.48	1.86	1.12	0.00	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	197.28	0.00	2.16	12.94	19.04	5.75	6.11	0.00	0.00	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	154.73	19.31	0.85	11.64	5.39	9.65	5.11	1.14	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	37.81	5.12	5.91	32.30	10.63	7.09	14.57	1.18	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	102.85	7.36	2.03	7.11	19.81	1.27	4.32	0.00	0.76	3.56
Smooth muscle cells - airway, control, donor2	11967-126D5	136.97	3.19	2.40	8.79	17.57	0.40	2.40	0.00	0.00	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	95.72	1.25	3.76	4.60	15.47	0.00	2.09	0.42	0.42	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	68.75	0.92	5.50	5.50	16.50	0.00	4.13	0.00	0.46	2.75
Synoviocyte, donor1	11291-117A4	142.74	0.84	0.84	15.82	13.97	9.93	9.26	0.34	0.34	8.75
Synoviocyte, donor2	11368-117I9	83.81	0.84	6.54	7.54	14.92	1.17	4.19	0.34	1.17	8.88
Synoviocyte, donor3	11440-118H9	128.68	2.23	6.48	12.96	25.25	3.35	5.36	0.22	0.67	14.30
Trabecular Meshwork Cells, donor1	11532-120A2	353.76	7.86	27.51	35.73	59.32	10.01	42.17	1.79	1.43	11.79
Trabecular Meshwork Cells, donor2	11612-122A1	69.37	3.96	3.96	13.87	11.89	7.93	7.93	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	281.10	4.40	24.54	25.24	36.58	7.87	23.15	1.39	2.08	9.03
Tracheal Epithelial Cells, donor1	11292-117A5	0.65	129.46	3.15	0.43	0.00	1.65	0.43	3.80	0.65	1.15
Tracheal Epithelial Cells, donor2	11369-118A1	4.64	224.98	3.48	1.16	0.00	0.39	0.00	6.57	0.77	2.32
Tracheal Epithelial Cells, donor3	11441-118I1	1.15	155.76	2.86	1.72	0.00	0.57	0.00	2.29	0.00	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	26.45	39.49	5.54	7.87	3.44	2.71	1.11	6.15	0.62	3.57
Urethra, donor2	10319-105A4	71.94	134.88	8.99	21.58	0.00	10.79	0.00	3.60	1.80	1.80
Urothelial Cells, donor1	11520-119H8	0.00	197.92	1.86	0.27	0.00	0.27	0.00	17.53	0.53	0.00
Urothelial Cells, donor2	11600-120H7	0.00	142.60	0.40	0.40	0.00	0.80	0.00	13.22	0.00	0.00
Urothelial Cells, donor3	11681-122H7	0.00	148.52	1.38	0.23	0.00	0.69	0.00	6.88	0.23	0.46
Urothelial cells, donor0	11216-116B1	0.67	121.92	1.56	0.00	0.00	0.45	0.00	8.25	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	62.28	0.89	135.25	0.00	0.00	0.89	0.00	0.00	8.01	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	47.18	0.00	144.39	1.43	0.00	0.00	0.00	0.00	7.15	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	56.82	0.00	78.04	1.37	0.00	0.68	0.00	0.00	6.85	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	58.19	0.34	118.11	0.34	0.00	1.72	0.00	0.00	7.58	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	48.81	0.00	91.22	0.58	0.00	1.74	0.00	0.00	8.13	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	57.27	0.00	125.99	0.00	0.00	1.04	0.00	0.00	6.25	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	44.97	0.00	137.67	1.84	0.00	0.00	0.00	0.00	7.34	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	52.95	1.83	81.25	0.91	0.00	0.00	0.00	0.00	1.83	0.91
Wilms' tumor cell line:G-401	10809-111A8	24.55	92.40	0.00	3.21	2.10	5.67	6.91	3.70	0.25	0.25
Wilms' tumor cell line:HFWT	10597-108E3	7.04	0.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	0.00	212.56	0.00	0.56	0.00	0.84	0.00	4.47	0.00	0.00
achilles tendon, donor2	10292-104G4	70.26	14.47	22.73	20.67	0.00	10.33	12.40	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	21.42	0.76	127.22	5.35	0.51	20.91	19.12	0.00	12.49	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	2.09	1.16	250.98	0.00	0.00	0.00	0.00	0.00	7.66	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	504.03	42.97	193.02	0.00	0.00	0.12	0.00	0.00	58.76	1.31
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	66.67	43.27	197.01	0.00	0.00	0.00	0.00	0.00	0.82	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	5.90	0.00	0.00	25.86	16.87	56.22	17.71	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	91.15	16.92	0.00	4.44	0.42	5.50	2.54	0.00	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	128.76	4.63	68.87	22.32	3.27	25.86	15.79	0.00	9.53	1.63
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	20.27	1.32	7.93	20.71	2.64	33.05	11.46	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	9.80	8.17	49.82	11.43	0.82	19.60	14.29	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	3.88	0.00	336.65	19.03	5.44	13.20	24.07	0.00	59.80	11.65
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.00	0.00	0.00	10.67	16.38	18.77	9.75	0.00	0.00	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	0.00	11.70	0.00	27.30	3.90	74.11	19.50	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	140.36	31.37	0.00	0.46	1.16	0.70	1.39	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	0.78	0.00	44.53	9.32	1.04	5.18	3.62	0.00	1.29	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	7.89	0.00	74.52	4.68	0.29	1.46	2.34	0.00	1.46	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	6.04	4.18	0.00	8.37	1.86	7.90	3.72	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	1.65	11.52	0.00	12.75	5.35	20.97	11.52	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	2.15	19.03	0.00	10.74	1.53	7.06	13.20	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	0.43	12.37	0.00	17.92	6.40	6.83	8.53	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	1.21	11.22	0.00	17.29	5.16	6.37	5.16	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	1.93	17.81	0.00	11.55	6.50	6.98	5.54	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	0.00	0.45	0.00	7.80	10.69	5.79	6.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	76.38	0.33	8.67	30.02	4.67	24.35	14.34	0.00	2.67	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	61.32	0.00	5.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	24.11	2.26	18.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	1.31	0.00	40.12	10.47	0.44	8.29	5.67	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	56.23	0.00	74.98	0.00	0.00	0.00	3.75	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	0.00	117.75	6.36	0.00	0.00	0.47	0.00	3.30	1.88	0.00
adipose tissue, adult, pool1	10010-101C1	29.63	20.79	3.72	13.34	15.05	6.20	3.72	0.16	0.16	3.26
adipose, donor1	10184-103D4	52.78	9.38	47.50	0.00	0.00	0.00	0.00	1.17	7.04	1.17
adipose, donor2	10185-103D5	77.45	13.38	55.56	0.00	0.00	0.00	0.00	0.00	2.03	0.81
adipose, donor3	10186-103D6	64.80	7.90	63.17	0.00	0.00	0.27	0.00	0.00	3.81	3.81
adipose, donor4	10187-103D7	60.67	44.20	43.34	0.00	0.87	0.00	0.00	0.00	4.33	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	18.31	18.94	3.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	156.42	0.00	0.00	3.64	0.00	14.55	14.55	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	9.34	0.00	71.37	5.20	0.27	9.87	0.27	1.47	27.48	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	0.00	46.45	2.14	18.22	4.64	42.52	10.36	43.95	0.36	1.79
amniotic membrane cells, donor1	12235-129G3	0.46	33.39	0.00	8.58	3.71	35.94	3.01	19.01	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	6.76	29.75	6.09	6.09	3.38	10.48	3.38	31.44	0.00	0.68
amniotic membrane cells, donor3	12237-129G5	0.00	19.15	0.00	12.37	3.83	49.79	1.47	42.13	0.00	0.00
amygdala - adult, donor10196	10167-103B5	27.27	1.19	35.57	1.19	0.00	0.00	1.19	0.00	5.93	5.93
amygdala, adult, donor10252	10151-102I7	54.34	0.00	26.36	2.84	1.42	1.22	0.81	0.00	2.43	3.45
amygdala, newborn, donor10223	10360-105E9	40.02	1.61	10.33	2.58	2.26	0.97	0.97	0.00	1.29	4.84
anaplastic carcinoma cell line:8305C	10428-106D5	1.91	54.24	3.18	10.57	4.58	1.78	7.51	7.00	0.13	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.00	1.76	0.00	35.08	1.99	58.69	7.72	0.44	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	55.45	24.72	36.08	0.00	0.00	0.00	0.00	0.00	2.67	1.34
aorta, adult, pool1	10052-101G7	96.11	7.45	4.51	16.28	3.92	6.67	10.79	1.77	0.20	0.59
appendix, adult	10189-103D9	70.25	19.41	112.55	4.66	0.39	3.49	3.88	0.78	17.47	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	2.06	125.88	17.88	0.00	0.00	0.00	0.00	1.03	4.82	0.00
artery, adult	10190-103E1	40.76	1.36	2.72	4.08	2.72	5.43	9.51	2.72	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	24.92	36.94	47.95	8.98	0.14	3.19	0.29	2.46	6.81	15.65
b cell line:RPMI1788	10427-106D4	0.30	18.89	92.49	16.06	1.04	44.02	7.73	0.00	25.13	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	91.00	1.39	0.28	20.53	14.15	8.88	6.66	1.39	0.00	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	0.10	209.38	0.69	4.66	1.98	16.08	7.54	5.85	0.00	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	1.67	103.44	4.02	2.18	1.34	14.39	1.17	12.55	0.84	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	6.15	1.68	50.33	11.74	0.00	1.68	6.15	0.00	0.56	0.56
bladder, adult, pool1	10011-101C2	98.21	30.53	15.54	15.21	7.06	4.67	6.84	0.76	2.61	4.24
blood, adult, pool1	10053-101G8	64.22	0.00	108.52	0.00	0.00	2.21	0.00	0.00	4.43	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	9.42	0.86	0.00	20.55	16.27	11.13	9.42	5.14	0.00	0.00
bone marrow, adult	10192-103E3	55.34	4.05	4.72	16.87	9.45	12.15	18.90	6.07	0.00	0.00
brain, adult, donor1	10084-102B3	53.30	6.15	25.63	4.10	1.03	1.03	10.25	0.00	0.00	1.03
brain, adult, pool1	10012-101C3	39.87	0.22	23.72	4.12	2.67	0.89	3.34	0.00	3.67	5.12
brain, fetal, pool1	10085-102B4	66.78	0.00	77.47	2.67	0.00	2.67	2.67	0.00	2.67	2.67
breast carcinoma cell line:MCF7	10482-107A5	0.00	156.26	0.00	0.00	0.00	0.00	0.00	15.53	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	0.12	132.06	2.87	0.00	0.00	0.00	0.00	19.72	0.00	0.25
breast, adult, donor1	10080-102A8	66.92	14.52	4.42	16.42	7.58	6.31	6.31	1.89	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	0.00	149.27	16.13	7.24	2.79	17.28	6.35	17.15	0.38	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	3.09	161.41	0.00	8.35	0.00	25.36	6.49	38.34	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	0.00	3.91	0.00	26.48	3.45	23.48	6.45	6.91	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	0.00	123.46	0.00	3.87	0.24	5.57	1.69	16.46	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	7.05	91.68	2.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	0.00	56.55	0.00	0.11	0.00	0.44	0.00	12.58	0.00	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	32.32	12.36	24.40	1.90	0.00	1.27	0.95	0.00	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	19.70	18.90	17.04	0.53	0.00	0.00	0.00	0.00	0.00	2.66
caudate nucleus - adult, donor10196	10177-103C6	42.60	0.00	23.03	2.30	0.00	0.00	1.15	0.00	0.00	2.30
caudate nucleus, adult, donor10252	10164-103B2	30.12	0.00	20.58	1.84	0.00	0.17	0.00	0.00	0.67	4.18
caudate nucleus, adult, donor10258	10379-105H1	11.46	0.00	9.17	0.00	0.00	0.00	0.00	0.00	0.00	1.53
caudate nucleus, newborn, donor10223	10354-105E3	40.29	1.46	8.79	1.10	0.00	1.46	0.37	0.00	0.73	5.13
cerebellum - adult, donor10196	10173-103C2	110.70	58.27	29.13	2.91	0.00	0.00	0.00	0.00	0.00	14.57
cerebellum, adult, donor10252	10166-103B4	128.11	37.36	17.29	0.85	0.21	0.21	0.00	0.00	1.07	20.71
cerebellum, adult, pool1	10083-102B2	93.83	14.83	10.69	0.34	0.00	0.00	0.00	0.00	2.41	8.28
cerebellum, newborn, donor10223	10357-105E6	91.33	11.62	29.06	0.00	0.83	0.00	0.83	0.83	0.83	23.25
cerebral meninges, adult	10188-103D8	36.06	2.02	16.89	8.07	1.76	2.77	4.54	0.00	1.76	3.28
cerebrospinal fluid, donor2	10294-104G6	21.20	7.31	6.58	4.39	0.73	7.31	0.73	2.19	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	0.00	54.35	0.00	5.75	2.01	3.45	10.35	4.31	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	0.00	127.93	0.00	0.33	0.00	0.66	0.00	17.23	0.17	0.00
cervix, adult, pool1	10013-101C4	101.74	28.87	13.02	13.54	12.70	2.83	9.87	5.14	0.10	9.97
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	0.00	66.19	0.00	3.20	3.48	0.98	1.53	8.92	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	9.14	5.23	0.00	18.29	0.00	2.61	2.61	16.98	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	22.74	109.11	0.00	0.00	0.00	0.00	0.00	0.00	0.25	0.12
choriocarcinoma cell line:SCH	10785-110H2	7.27	7.64	27.72	2.71	0.00	1.36	1.48	0.12	18.61	1.11
choriocarcinoma cell line:T3M-3	10618-108G6	14.94	65.70	18.97	2.13	0.24	0.95	1.19	0.00	0.95	0.24
chorionic membrane cells, donor1	12238-129G6	4.84	56.98	0.85	4.56	1.71	8.26	1.42	5.13	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	93.56	35.40	6.46	14.91	7.16	5.87	8.05	9.25	0.20	2.49
chorionic membrane cells, donor3	12240-129G8	12.09	86.82	0.55	4.40	1.10	4.40	2.20	2.20	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	47.46	41.40	88.86	0.00	0.00	0.00	0.00	0.00	3.03	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	0.19	0.77	31.50	22.86	3.84	19.79	11.53	0.00	2.11	0.96
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	13.30	0.42	20.27	9.29	0.42	6.76	7.39	0.00	0.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	9.24	5.91	12.58	12.07	1.80	16.69	8.99	0.00	2.82	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	12.58	12.58	11.85	20.08	3.39	14.51	12.34	0.00	1.45	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	20.77	15.07	7.94	16.29	3.05	13.23	10.38	0.00	2.44	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	1.47	0.88	4.12	17.37	3.53	20.02	7.95	0.00	0.88	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	10.69	1.30	34.40	25.80	1.82	26.32	19.03	0.00	0.26	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	0.00	133.26	0.00	12.80	1.83	17.14	14.63	5.49	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	0.00	96.47	0.00	0.00	0.17	0.52	0.00	3.82	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	0.00	114.58	61.87	0.18	0.00	0.55	0.00	0.00	19.04	0.73
colon carcinoma cell line:COLO-320	10420-106C6	0.00	17.86	187.38	0.00	0.00	0.00	0.00	0.38	14.82	0.00
colon, adult, donor1	10082-102B1	108.29	94.01	14.28	7.14	2.38	2.38	13.09	0.00	2.38	0.00
colon, adult, pool1	10014-101C5	65.92	40.42	24.91	6.70	3.17	4.82	1.76	1.76	11.16	1.41
colon, fetal, donor1	10070-101I7	118.04	45.11	23.48	4.94	0.62	1.85	4.94	0.00	3.71	0.62
common myeloid progenitor CMP, donor1	12130-128D6	87.09	13.75	36.67	9.17	0.00	9.17	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	8.92	0.85	50.14	2.12	0.00	1.27	0.00	0.00	22.95	1.70
cord blood derived cell line:COBL-a 24h infection	10453-106G3	23.09	0.15	84.82	2.72	0.00	1.21	0.00	0.00	41.20	0.91
cord blood derived cell line:COBL-a untreated	10449-106F8	22.98	0.00	99.41	2.40	0.00	1.41	0.00	0.00	48.23	0.71
corpus callosum, adult, pool1	10042-101F6	53.62	4.09	45.00	1.44	0.00	0.66	0.77	0.77	4.64	4.53
cruciate ligament, donor2	10295-104G7	66.46	4.05	8.10	21.88	1.62	18.64	4.05	0.00	0.00	3.24
diaphragm, fetal, donor1	10069-101I6	93.10	0.80	8.03	7.22	3.21	1.61	1.61	1.61	0.80	4.01
diencephalon, adult	10193-103E4	30.00	0.72	17.76	0.00	0.00	0.00	0.00	0.00	1.68	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.46	0.00	219.28	0.23	0.00	0.00	0.23	0.00	49.37	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	0.00	227.46	0.00	0.51	0.00	0.00	0.00	42.57	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	0.00	57.05	0.00	6.02	0.48	10.83	3.37	6.74	0.00	0.00
ductus deferens, adult	10196-103E7	43.36	72.26	5.48	2.99	2.99	1.99	3.99	1.99	0.50	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	103.70	59.05	24.48	0.00	0.00	7.20	4.32	0.00	2.88	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	113.29	53.70	33.84	2.21	1.47	4.41	3.68	0.74	1.47	0.74
dura mater, adult, donor1	10041-101F5	70.45	13.96	18.17	17.34	7.52	4.54	4.29	0.25	0.33	1.32
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	6.22	19.76	2.00	11.55	0.44	12.66	1.78	0.22	0.44	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	27.94	41.41	7.88	6.88	0.72	5.45	0.72	2.01	0.29	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	0.00	113.46	1.23	4.32	0.62	27.75	4.32	23.43	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	0.00	72.05	0.30	9.69	0.00	13.32	4.24	29.06	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	0.00	98.49	1.54	13.89	0.62	26.55	3.70	29.95	0.31	0.62
embryonic pancreas cell line:2C6	10603-108E9	0.00	123.47	2.63	11.82	0.00	18.39	5.25	30.21	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	10.39	48.60	0.00	1.68	0.00	3.02	0.00	26.48	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	0.00	31.53	0.91	16.31	2.36	3.44	10.87	37.70	0.18	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	87.48	83.94	2.41	0.00	0.00	0.00	0.00	18.82	0.32	1.29
epidermoid carcinoma cell line:A431	10426-106D3	0.00	169.29	0.11	0.22	0.00	0.22	0.00	4.78	0.33	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	0.11	226.57	0.00	0.00	0.00	0.11	0.00	19.91	0.00	0.00
epididymis, adult	10197-103E8	65.51	28.05	6.70	5.86	2.72	1.67	1.67	8.37	1.47	2.93
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	0.00	39.56	0.00	11.53	4.44	22.89	7.45	2.31	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	0.00	30.28	0.00	2.75	1.97	1.18	1.97	9.83	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	0.00	114.14	0.26	7.08	1.44	6.95	4.85	12.19	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	0.00	133.85	0.00	7.18	1.48	7.48	5.31	13.68	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	0.00	119.54	0.00	6.72	1.46	7.06	5.94	16.58	0.00	0.00
esophagus, adult, pool1	10015-101C6	71.78	33.76	7.33	8.49	4.46	6.05	2.65	0.85	1.17	2.97
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	2.00	160.43	0.38	0.00	0.00	0.00	0.00	3.76	0.00	0.38
eye - muscle inferior rectus, donor1	10272-104E2	45.88	7.24	0.00	12.07	2.41	0.00	0.00	0.00	0.00	9.66
eye - muscle lateral, donor2	10298-104H1	39.98	4.21	4.21	4.21	0.00	10.52	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	66.97	0.00	4.46	2.98	0.00	2.98	4.46	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	68.79	5.73	10.32	5.73	0.00	4.59	2.29	0.00	1.15	6.88
eye - vitreous humor, donor1	10268-104D7	45.18	13.12	20.40	2.91	0.00	2.91	2.91	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	55.42	10.93	11.95	2.54	2.54	2.54	3.56	1.02	0.51	3.31
fibrosarcoma cell line:HT-1080	10758-110E2	0.13	6.03	0.00	13.34	2.05	12.69	7.31	17.44	0.00	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	16.38	4.04	0.24	26.35	3.09	25.40	13.30	2.85	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	33.50	0.28	24.21	6.47	2.91	0.84	5.82	0.00	3.00	5.44
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	0.00	138.41	0.00	0.00	0.00	1.20	0.00	28.52	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	0.09	173.73	0.00	1.01	0.09	3.66	0.27	17.37	0.00	0.00
gall bladder, adult	10198-103E9	90.78	115.40	9.42	5.79	1.93	10.14	7.48	9.66	1.21	1.69
gamma delta positive T cells, donor1	11937-126A2	113.28	0.00	154.61	0.00	0.00	0.54	0.00	0.00	2.15	0.00
gamma delta positive T cells, donor2	11938-126A3	78.06	0.37	186.75	0.00	0.00	0.37	0.00	0.00	2.24	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	0.00	77.94	0.00	0.84	0.42	4.22	0.63	20.07	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	0.00	199.02	0.39	3.87	0.19	8.12	1.74	25.72	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	22.13	35.41	55.58	0.00	0.00	0.00	0.00	0.33	2.46	0.82
gastric cancer cell line:GSS	10560-108A2	57.66	64.07	235.21	0.00	0.00	0.00	0.00	0.00	75.05	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	3.43	53.46	1.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	0.00	43.95	0.00	5.62	0.23	7.11	1.26	3.21	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	1.96	172.85	1.12	8.12	1.96	18.75	5.32	57.52	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	0.00	151.40	0.00	0.00	0.00	0.25	0.00	18.21	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	0.00	38.74	0.00	17.10	7.18	15.41	8.44	80.43	0.00	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	0.00	32.44	0.00	17.98	8.01	20.93	11.94	65.87	0.00	0.00
glioblastoma cell line:T98G	10485-107A8	72.74	3.09	6.29	14.79	13.91	8.72	16.56	5.19	0.00	0.11
glioma cell line:GI-1	10413-106B8	17.87	3.22	2.34	16.40	11.42	9.66	13.18	1.46	0.00	0.59
globus pallidus - adult, donor10196	10175-103C4	30.61	0.00	30.61	0.00	0.00	0.73	0.00	0.00	0.73	2.19
globus pallidus, adult, donor10252	10161-103A8	59.56	0.24	29.54	2.93	0.49	0.73	0.24	0.00	0.49	2.69
globus pallidus, adult, donor10258	10367-105F7	31.49	0.00	6.85	1.37	0.00	0.00	0.00	0.00	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	35.17	1.60	9.59	3.73	0.53	3.20	1.07	0.00	1.07	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	97.89	19.58	112.57	24.47	0.00	7.34	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	0.00	32.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	0.00	26.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	0.00	171.52	0.00	3.84	0.32	5.44	0.96	9.92	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	84.94	42.24	46.37	0.46	0.46	0.92	0.00	0.46	6.43	3.21
hIPS +CCl2, biol_rep2	14384-156C1	85.05	53.04	43.44	0.91	0.00	0.00	0.00	0.00	2.74	2.29
hIPS +CCl2, biol_rep3	14385-156C2	94.04	53.46	54.75	0.00	0.64	0.00	0.64	0.00	4.51	0.64
hIPS, biol_rep1	14380-156B6	77.61	43.12	45.99	0.00	0.00	0.00	0.00	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	81.62	37.04	52.81	0.00	0.00	0.00	0.00	0.00	3.43	2.06
hIPS, biol_rep3	14382-156B8	44.14	8.83	13.24	0.00	1.10	0.00	0.00	0.00	3.31	0.00
hairy cell leukemia cell line:Mo	10712-109I1	15.23	0.57	166.95	0.00	0.00	0.00	0.00	0.00	47.70	1.44
heart - mitral valve, adult	10205-103F7	45.74	2.09	3.89	5.38	1.79	1.20	2.69	0.90	0.00	2.09
heart - pulmonic valve, adult	10206-103F8	68.77	1.83	4.97	2.35	1.05	0.00	2.35	0.78	0.78	3.14
heart - tricuspid valve, adult	10207-103F9	47.46	0.83	0.00	23.31	5.83	9.99	2.50	0.00	0.00	5.83
heart, adult, diseased post-infarction, donor1	10050-101G5	40.00	20.20	3.67	4.69	2.04	0.61	2.04	1.22	0.41	4.08
heart, adult, diseased, donor1	10051-101G6	59.62	1.70	3.41	2.98	2.98	2.13	0.85	0.00	0.00	6.39
heart, adult, pool1	10016-101C7	40.25	1.61	3.22	7.59	2.07	0.92	1.61	0.23	0.00	6.90
heart, fetal, pool1	10046-101G1	74.65	3.70	17.35	3.90	1.44	1.03	1.44	0.72	0.62	14.38
hepatic mesenchymal tumor cell line:LI90	10778-110G4	96.26	10.49	0.62	8.02	4.63	4.94	15.43	4.63	0.00	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	0.00	104.65	28.54	0.00	0.00	0.00	0.00	0.00	21.41	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	111.27	265.96	78.89	0.00	0.00	0.00	0.00	2.98	59.78	4.64
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	98.56	287.66	90.79	0.00	0.00	0.00	0.00	2.06	61.66	3.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	112.47	299.42	94.48	0.00	0.00	0.00	0.00	2.83	67.20	4.14
hepatoma cell line:Li-7	10484-107A7	42.37	142.13	0.00	0.33	0.00	0.44	0.00	4.78	0.00	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	0.20	0.00	96.08	0.00	0.00	0.00	0.00	0.00	55.58	1.11
hippocampus - adult, donor10196	10169-103B7	23.66	0.00	26.50	1.89	0.00	0.95	0.00	0.00	1.89	5.68
hippocampus, adult, donor10252	10153-102I9	68.37	1.22	25.51	2.25	0.61	0.20	0.20	0.00	0.82	2.65
hippocampus, adult, donor10258	10374-105G5	33.36	1.49	15.44	7.97	1.49	1.00	5.98	0.00	3.49	6.97
hippocampus, newborn, donor10223	10363-105F3	27.49	1.76	5.29	1.41	0.35	1.41	0.00	0.00	1.06	3.88
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	59.81	54.93	37.23	0.00	0.00	0.00	0.00	1.22	1.83	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	56.75	59.69	47.13	0.00	0.00	0.00	0.00	0.59	1.77	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	57.89	63.73	51.29	0.00	0.00	0.00	0.00	2.03	1.27	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	119.54	21.99	74.43	0.00	0.00	0.00	0.00	1.13	3.95	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	139.18	27.37	85.21	0.00	0.00	0.00	0.00	1.03	5.68	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	111.61	26.19	97.56	0.00	0.00	0.00	0.00	0.00	8.35	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	73.86	7.01	92.55	0.29	0.00	0.00	0.00	0.00	4.38	3.21
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	97.80	15.30	96.51	0.00	0.00	0.00	0.00	0.22	5.17	3.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	63.81	11.68	114.28	0.00	0.00	0.42	0.00	0.00	2.50	3.75
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	38.83	5.68	71.75	0.00	0.00	0.00	0.00	0.47	2.13	6.63
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	74.57	9.64	91.93	0.16	0.00	0.00	0.00	0.16	2.25	4.66
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	44.44	9.43	86.18	0.00	0.00	0.00	0.00	0.67	1.35	5.39
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	58.37	58.99	41.62	0.00	0.00	0.00	0.00	0.63	2.03	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	58.46	55.52	46.67	0.00	0.00	0.00	0.00	0.00	1.47	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	24.44	32.29	25.31	0.00	0.00	0.00	0.00	0.87	1.75	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	141.46	28.25	84.57	0.00	0.00	0.00	0.00	1.15	9.93	1.53
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	155.68	26.60	86.78	0.00	0.00	0.00	0.00	0.87	8.29	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	104.45	17.49	70.47	0.00	0.00	0.00	0.00	0.50	3.00	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	69.89	27.69	63.49	0.00	0.00	0.00	0.00	0.00	3.96	2.64
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	63.21	24.10	81.39	0.00	0.00	0.00	0.00	0.00	5.46	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	57.32	17.23	65.15	0.00	0.00	0.00	0.00	0.31	5.95	2.51
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	41.32	3.59	52.26	0.33	0.00	0.00	0.00	0.00	3.92	4.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	40.06	6.68	60.67	0.58	0.00	0.29	0.00	0.58	2.03	5.23
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	49.02	5.08	67.86	0.00	0.30	0.00	0.30	0.90	3.59	2.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	59.86	64.29	41.75	0.37	0.18	0.00	0.18	1.66	2.96	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	79.02	66.19	46.50	0.00	0.00	0.00	0.00	0.29	3.71	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	55.94	62.06	44.10	0.00	0.00	0.00	0.00	1.63	3.67	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	125.34	22.18	84.15	0.00	0.00	0.00	0.35	1.06	8.80	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	114.03	25.34	75.38	0.00	0.32	0.32	0.32	1.90	8.24	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	105.61	20.58	69.30	0.00	0.00	0.00	0.00	2.12	9.68	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	68.26	10.86	87.39	0.52	0.00	0.00	0.00	1.03	5.17	3.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	66.42	15.28	78.37	0.00	0.00	0.00	0.00	0.00	3.98	5.31
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	53.62	11.29	93.12	0.00	0.00	0.26	0.00	0.00	5.64	5.64
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	61.61	6.39	72.09	0.51	0.26	0.26	0.00	0.26	5.11	8.44
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	62.85	4.54	87.08	0.00	0.00	0.00	0.00	0.00	4.54	6.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	50.74	4.03	64.19	1.01	0.00	0.00	0.34	0.67	3.36	6.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	70.28	75.59	38.64	0.00	0.00	0.00	0.00	0.72	1.69	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	52.14	55.26	44.57	0.00	0.00	0.00	0.00	0.45	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	79.03	68.78	38.05	0.00	0.00	0.00	0.00	0.00	1.95	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	146.39	23.53	94.13	0.00	0.00	0.00	0.00	1.22	10.70	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	55.31	22.77	87.84	0.00	0.00	0.00	0.00	6.51	13.01	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	104.25	24.49	82.07	0.00	0.00	0.00	0.00	1.99	9.60	2.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	98.51	16.42	134.09	0.00	0.00	0.00	0.00	0.00	8.21	3.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	73.82	11.58	100.60	0.00	0.00	0.00	0.00	0.00	2.90	4.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	67.26	9.61	87.90	0.00	0.00	0.00	0.00	0.00	2.14	3.91
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	57.28	3.58	54.90	0.00	0.00	0.00	0.00	0.00	3.58	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	55.25	3.79	78.95	0.41	0.00	0.00	0.27	0.14	4.88	5.82
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	51.72	2.69	59.81	0.81	0.00	0.00	0.00	0.27	2.42	3.23
immature langerhans cells, donor1	11904-125F5	22.52	5.09	20.10	3.87	0.00	31.72	0.00	0.00	0.48	0.48
immature langerhans cells, donor2	11905-125F6	8.71	41.19	15.84	10.30	0.00	35.65	2.38	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	42.02	0.47	31.70	5.39	2.84	1.42	5.11	0.00	3.97	8.71
keratoacanthoma cell line:HKA-1	10791-110H8	0.00	73.16	0.00	0.00	0.00	0.00	0.00	0.33	0.00	0.00
kidney, adult, pool1	10017-101C8	46.36	45.16	6.81	4.71	1.70	1.80	1.10	3.40	0.60	1.10
kidney, fetal, pool1	10045-101F9	62.04	80.29	25.46	4.60	3.47	1.70	5.09	1.77	1.98	4.60
large cell lung carcinoma cell line:IA-LM	10509-107D5	0.00	37.35	0.00	11.65	1.28	26.98	9.80	21.30	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	0.00	46.31	0.00	4.70	2.49	9.54	2.21	30.41	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	0.00	122.58	0.00	0.73	0.00	0.55	0.55	5.32	0.00	0.00
left atrium, adult, donor1	10079-102A7	60.48	3.27	6.54	3.27	1.09	2.72	0.54	2.18	0.00	0.54
left ventricle, adult, donor1	10078-102A6	53.09	0.51	3.03	6.07	0.51	3.03	1.52	0.00	0.00	1.01
leiomyoblastoma cell line:G-402	10721-110A1	29.55	76.34	0.00	0.00	0.00	0.55	0.00	10.12	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	202.98	0.00	0.72	14.37	6.83	4.67	5.39	0.00	0.36	1.08
leiomyoma cell line:15242A	10570-108B3	85.33	1.63	2.17	8.70	4.89	8.15	2.72	0.00	0.00	1.63
leiomyoma cell line:15425	10571-108B4	170.21	2.43	2.19	17.73	13.60	12.14	7.28	0.24	0.49	2.19
leiomyosarcoma cell line:Hs 5.T	10722-110A2	44.45	0.00	0.00	12.70	6.35	0.00	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	2.09	25.09	2.09	0.00	0.00	2.09	0.00	11.50	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	12.87	0.12	0.59	6.97	0.35	5.19	2.60	0.00	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	8.12	7.81	0.00	37.80	11.09	45.14	12.34	28.27	0.16	0.31
liposarcoma cell line:SW 872	10726-110A6	77.61	26.80	4.51	22.91	3.17	32.53	21.93	5.48	0.12	1.22
liver, adult, pool1	10018-101C9	8.75	48.29	5.35	1.62	0.00	0.16	0.65	34.84	2.27	0.49
liver, fetal, pool1	10086-102B5	28.22	56.44	4.70	1.88	0.94	0.94	0.00	1.88	0.94	0.94
locus coeruleus - adult, donor10196	10182-103D2	73.93	1.46	21.87	3.21	0.44	1.46	0.29	0.00	1.31	2.62
locus coeruleus, adult, donor10252	10165-103B3	69.21	0.74	12.92	1.85	0.00	0.74	0.18	0.00	0.55	2.58
locus coeruleus, adult, donor10258	10375-105G6	65.74	0.28	16.08	0.00	0.00	0.28	0.56	0.00	1.69	2.82
locus coeruleus, newborn, donor10223	10362-105F2	46.69	2.10	6.31	6.31	1.68	1.26	0.84	0.00	1.26	6.31
lung adenocarcinoma cell line:A549	10499-107C4	0.00	53.84	0.00	4.43	0.28	12.32	1.66	9.96	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	0.00	35.16	0.00	0.00	0.69	2.76	0.69	11.72	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	0.13	54.84	0.00	2.24	0.66	12.39	1.32	9.89	0.00	0.00
lung, adult, pool1	10019-101D1	40.87	18.90	14.29	8.98	5.43	6.97	1.89	1.30	1.18	1.89
lung, fetal, donor1	10068-101I5	121.87	50.23	21.69	5.99	1.43	1.71	2.57	0.86	2.57	5.99
lung, right lower lobe, adult, donor1	10075-102A3	76.52	32.08	11.00	6.87	5.04	9.16	2.29	0.00	0.92	0.00
lymph node, adult, donor1	10077-102A5	95.15	6.63	80.47	6.15	3.31	2.84	2.37	0.00	4.73	0.95
lymphangiectasia cell line:DS-1	10727-110A7	50.63	0.00	82.19	3.07	0.00	8.33	3.51	0.00	4.82	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	2.57	0.91	188.36	2.11	0.45	6.34	0.30	0.00	15.85	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	0.00	96.84	0.00	1.70	0.00	1.70	0.00	16.14	0.00	0.00
mature adipocyte, donor1	12231-129F8	9.77	3.55	0.89	12.88	1.33	4.88	0.44	0.00	0.00	2.22
mature adipocyte, donor2	12232-129F9	16.60	1.66	1.25	11.41	6.02	3.94	1.45	0.00	0.00	1.25
mature adipocyte, donor3	12233-129G1	7.59	0.71	0.47	15.17	6.40	4.50	2.37	0.00	0.00	1.66
mature adipocyte, donor4	12234-129G2	4.47	1.58	0.00	10.79	8.69	2.37	1.32	0.00	0.00	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	61.95	60.28	35.26	0.00	0.00	0.00	0.00	5.96	4.05	1.67
medial frontal gyrus - adult, donor10196	10170-103B8	29.33	1.13	14.66	6.77	2.26	6.77	4.51	0.00	2.26	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	65.29	0.55	22.80	11.95	1.47	2.76	4.41	0.00	0.55	3.31
medial frontal gyrus, adult, donor10258	10368-105F8	28.27	0.00	11.75	6.67	1.59	1.91	11.75	0.00	1.27	2.22
medial frontal gyrus, newborn, donor10223	10352-105E1	16.21	0.00	5.97	3.41	2.13	2.13	4.69	0.00	1.71	3.84
medial temporal gyrus - adult, donor10196	10183-103D3	41.85	0.00	22.61	4.56	2.36	1.52	5.06	0.00	2.03	3.54
medial temporal gyrus, adult, donor10252	10156-103A3	64.73	0.42	23.13	11.67	2.12	4.03	4.03	0.00	0.21	3.61
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	28.89	0.00	5.78	5.78	1.93	1.93	5.78	0.00	0.00	5.78
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	0.00	14.35	14.35	0.00	0.00	0.00	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	28.71	1.44	7.90	3.23	2.51	0.36	3.59	0.00	0.72	5.74
medulla oblongata - adult, donor10196	10174-103C3	49.32	24.01	27.26	5.19	0.65	3.24	1.95	1.30	2.60	3.89
medulla oblongata, adult, donor10252	10155-103A2	98.15	11.77	12.69	2.48	0.31	0.62	0.62	1.08	1.24	3.10
medulla oblongata, adult, pool1	10038-101F2	86.52	3.92	30.12	2.04	0.57	0.57	0.90	0.16	4.08	3.18
medulla oblongata, newborn, donor10223	10361-105F1	70.48	2.43	9.03	3.12	2.78	0.69	0.69	0.00	0.69	7.64
medulloblastoma cell line:D283 Med	10838-111E1	54.47	74.84	32.77	0.00	0.00	0.00	0.00	2.88	0.22	0.44
medulloblastoma cell line:ONS-76	10759-110E3	34.48	124.35	42.80	0.00	0.00	0.49	0.00	2.93	3.91	8.19
melanoma cell line:COLO 679	10514-107E1	0.00	3.59	12.36	16.24	109.25	19.84	14.52	0.00	2.44	1.72
melanoma cell line:G-361	10465-106H6	0.27	0.81	46.96	24.16	83.88	8.14	16.02	0.00	14.12	9.23
meningioma cell line:HKBMM	10691-109F7	7.78	133.69	1.81	2.53	1.99	4.52	1.63	16.64	0.18	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	2.64	173.59	1.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	36.29	152.94	40.70	0.00	0.00	0.00	0.00	0.26	0.00	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	55.08	13.96	5.52	36.67	42.65	17.34	15.04	0.77	0.46	9.05
mesenchymal precursor cell - adipose, donor2	11748-123G2	36.54	1.27	3.82	8.91	22.54	2.54	8.54	0.00	0.55	1.82
mesenchymal precursor cell - adipose, donor3	11749-123G3	120.92	9.94	3.73	25.67	23.19	8.70	14.91	0.00	0.83	12.01
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	43.55	4.92	0.56	23.18	25.57	5.06	9.83	0.98	0.00	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	45.64	2.89	1.16	24.46	22.72	5.01	8.86	1.54	0.00	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	191.57	9.02	2.08	18.05	38.17	5.55	7.63	0.69	0.69	22.21
mesenchymal precursor cell - cardiac, donor1	11752-123G6	49.95	5.49	1.72	7.90	5.49	5.15	4.63	0.17	0.69	1.37
mesenchymal precursor cell - cardiac, donor2	11753-123G7	99.26	12.42	2.53	20.47	18.98	5.87	11.96	0.35	1.27	10.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	76.13	4.11	4.77	16.84	20.82	6.23	11.54	0.93	0.40	5.31
mesenchymal precursor cell - cardiac, donor4	11755-123G9	27.41	14.18	1.35	15.66	18.23	6.89	5.94	0.81	0.27	1.35
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	56.05	7.40	1.71	25.47	9.67	6.26	6.97	1.00	0.14	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	35.57	3.95	0.66	6.26	9.22	2.96	2.63	0.99	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	68.49	21.45	3.32	11.07	12.04	2.35	5.67	1.11	0.14	1.38
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	109.61	19.20	4.54	19.20	19.55	5.93	11.17	0.00	0.00	2.79
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	50.84	15.11	1.02	12.86	6.74	3.06	4.08	1.22	0.00	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	47.09	17.61	3.95	5.03	12.58	5.39	8.27	2.88	0.36	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	20.69	18.21	0.21	5.79	16.76	0.41	0.31	0.62	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	56.31	35.57	0.23	4.79	4.79	1.14	0.46	1.37	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	44.89	27.69	2.52	17.20	11.33	12.59	5.45	0.84	0.42	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	50.81	2.24	0.75	14.94	12.70	4.18	6.43	0.45	0.00	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	26.70	42.01	1.40	9.63	12.34	1.14	1.66	2.80	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	32.77	9.94	0.74	20.99	7.36	4.79	12.15	0.74	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	78.41	16.31	4.86	10.30	7.44	4.29	7.44	2.86	0.29	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	45.47	2.95	3.37	9.26	9.68	13.89	11.37	8.42	0.00	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	78.09	4.57	2.74	14.61	24.20	7.31	10.05	0.46	0.46	3.20
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	71.88	3.07	3.07	10.49	23.79	4.60	8.95	0.00	0.00	2.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	70.41	4.45	3.40	10.73	24.08	7.33	9.16	0.26	0.26	2.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	73.32	3.08	5.55	12.63	26.50	6.16	11.40	0.00	0.31	3.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	70.14	5.41	3.06	10.59	24.95	5.65	7.06	0.00	0.24	4.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	72.77	2.71	3.38	11.17	32.83	8.46	10.15	0.68	0.00	4.06
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	78.99	3.14	4.72	8.25	27.51	10.61	11.79	0.00	0.00	3.54
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	70.90	4.17	4.63	11.58	25.02	6.49	7.88	0.00	0.00	5.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	93.16	2.88	5.48	16.15	37.21	5.77	12.98	0.58	0.00	4.33
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	78.53	6.69	3.79	12.94	31.90	5.35	10.26	0.22	0.45	5.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	78.11	4.81	3.85	12.74	25.24	7.21	9.37	0.48	0.24	6.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	103.40	4.40	2.93	11.00	23.47	4.40	8.07	0.00	0.73	5.13
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	81.56	2.69	2.35	9.06	24.17	3.36	10.41	0.34	0.67	6.04
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	70.41	2.87	3.28	15.97	26.20	4.91	10.64	0.00	0.41	4.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	76.46	5.15	3.87	12.46	23.63	7.30	9.02	0.43	0.43	3.87
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	98.44	2.73	2.73	10.94	30.08	8.20	13.67	0.00	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	87.80	0.00	0.00	5.16	25.82	5.16	15.49	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	68.53	6.17	4.87	13.64	25.01	4.87	13.97	0.32	0.00	3.90
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	78.57	5.82	1.45	11.64	40.74	7.27	14.55	0.00	1.45	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	99.15	5.86	3.73	11.73	25.59	8.53	18.66	0.53	0.00	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	72.78	4.09	3.27	12.27	16.36	7.36	14.72	0.00	0.00	4.09
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	90.18	5.83	6.22	10.88	19.05	7.00	12.05	0.00	0.00	4.28
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	90.25	6.30	2.10	6.30	14.69	10.49	12.59	0.00	0.00	4.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	90.41	5.96	1.99	7.95	25.83	6.95	17.88	0.00	0.00	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	61.97	4.77	0.00	4.77	14.30	4.77	28.60	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	77.68	1.78	4.15	15.42	21.94	8.30	18.97	0.00	0.00	3.56
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	121.85	4.87	7.31	12.18	18.28	8.53	21.93	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	135.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	84.24	5.70	6.97	12.67	20.27	3.80	11.40	0.00	0.00	5.07
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	60.01	1.03	4.14	7.59	9.66	0.00	2.76	0.00	0.00	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	60.18	2.15	4.30	2.15	6.45	0.00	2.15	0.00	0.00	4.30
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	35.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	41.33	0.00	6.89	0.00	17.22	0.00	3.44	0.00	0.00	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	50.12	0.41	4.89	2.04	11.82	0.41	2.85	0.00	0.41	6.52
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	50.05	0.79	7.15	3.18	15.09	0.79	0.79	0.00	0.00	7.15
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	35.96	0.00	2.95	4.72	10.02	0.00	3.54	0.00	0.00	8.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	43.95	0.00	3.74	5.30	9.35	0.94	1.25	0.00	0.31	6.86
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	64.16	0.00	6.68	6.68	16.04	0.00	4.01	0.00	1.34	10.69
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	87.52	0.00	0.00	1.18	8.28	1.18	1.18	0.00	0.00	3.55
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	97.58	0.00	2.57	2.57	12.84	0.00	2.57	0.00	0.00	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	88.80	0.69	0.00	6.88	11.70	0.00	2.75	0.00	0.00	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	36.62	2.97	0.49	7.92	38.10	0.99	1.98	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	37.01	1.12	1.12	6.73	43.74	0.00	2.24	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	36.26	1.91	0.00	7.63	31.80	0.64	2.54	0.00	0.00	2.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	8.87	7.66	0.00	14.10	65.28	3.63	3.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	8.72	10.90	0.00	8.72	67.60	4.36	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	19.01	2.53	1.27	13.94	74.76	6.34	2.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	14.57	1.82	0.00	11.53	18.81	1.82	3.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	4.52	0.00	0.00	36.15	4.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	15.65	1.65	0.00	5.77	25.53	4.12	2.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	23.61	0.60	1.39	5.95	18.26	0.79	3.37	0.00	0.00	1.98
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	33.75	0.32	2.92	8.11	23.04	0.00	4.54	0.00	0.32	1.95
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	36.67	0.00	2.04	7.13	27.50	2.04	0.00	0.00	0.00	5.09
mesodermal tumor cell line:HIRS-BM	10696-109G3	41.01	0.00	1.55	17.02	0.00	0.77	1.55	5.42	0.00	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	0.00	39.69	0.00	14.65	0.94	24.33	5.91	28.35	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	2.55	109.58	12.51	0.00	0.00	0.00	0.23	3.48	0.23	0.93
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	51.28	132.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	54.87	77.99	0.31	0.72	0.00	0.51	0.00	4.32	0.10	0.72
mesothelioma cell line:Mero-25	10850-111F4	4.31	140.94	2.04	2.27	1.36	2.95	2.72	3.18	0.68	0.23
mesothelioma cell line:Mero-41	10851-111F5	0.24	227.85	0.00	2.44	1.96	2.69	3.18	11.25	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	0.00	223.20	0.00	7.97	2.44	3.76	6.86	9.74	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	0.00	89.09	0.00	4.99	4.20	10.78	5.26	4.99	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	0.00	260.78	2.55	1.53	0.00	0.85	0.00	16.51	0.68	2.72
mesothelioma cell line:Mero-84	10855-111F9	16.43	201.97	21.74	0.00	0.00	0.00	0.00	4.80	2.27	3.54
mesothelioma cell line:Mero-95	10856-111G1	0.21	186.96	0.00	0.00	0.00	0.00	0.00	12.42	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	0.00	151.90	3.31	14.08	7.29	9.28	10.77	6.13	0.00	0.33
mesothelioma cell line:NCI-H226	10846-111E9	0.18	272.39	0.18	0.18	0.18	0.00	0.00	3.44	0.18	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	13.15	147.76	1.37	0.34	0.00	0.00	0.00	3.07	0.17	0.17
mesothelioma cell line:NCI-H28	10845-111E8	38.42	223.17	9.92	7.38	3.82	31.04	2.80	9.16	2.80	1.53
mesothelioma cell line:No36	10857-111G2	0.33	22.18	12.07	1.30	0.00	5.22	0.00	16.31	1.30	0.00
mesothelioma cell line:ONE58	10858-111G3	8.94	130.06	3.79	2.71	2.98	5.69	4.06	13.28	0.27	0.81
migratory langerhans cells, donor1	11901-125F2	7.48	4.03	7.29	6.53	0.38	4.22	0.19	0.00	1.15	0.00
migratory langerhans cells, donor2	11902-125F3	12.70	4.88	15.26	4.40	0.12	2.69	0.00	0.00	1.34	0.00
migratory langerhans cells, donor3	11903-125F4	8.79	8.08	18.67	5.20	0.90	4.49	0.36	0.00	0.36	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	0.00	56.81	0.00	0.98	4.90	6.86	5.88	2.29	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	0.00	108.09	0.00	2.33	0.64	1.06	1.70	42.60	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	0.00	115.18	1.38	1.15	0.46	8.29	0.23	4.15	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	37.11	84.49	111.51	3.04	0.00	0.76	0.00	0.00	22.26	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	0.00	9.79	0.00	25.87	8.13	21.99	10.16	0.00	0.00	0.00
myeloma cell line:PCM6	10474-106I6	0.00	0.00	53.37	0.00	0.00	0.00	0.00	0.00	4.74	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	8.62	6.59	4.57	29.93	3.04	19.28	12.68	20.29	0.00	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	86.69	0.00	5.10	42.37	19.81	22.95	6.28	0.00	0.00	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	0.00	38.44	0.33	0.67	0.22	1.56	0.11	2.23	0.22	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	0.07	35.67	0.15	0.96	0.07	1.84	0.07	1.54	0.07	0.00
nasal epithelial cells, donor2	12227-129F4	3.31	99.91	7.18	1.66	0.55	1.66	0.55	1.10	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	37.73	1.38	199.23	0.00	0.00	0.00	0.00	0.00	4.83	1.84
neuroblastoma cell line:NB-1	10539-107G8	76.14	1.87	135.08	0.19	0.00	0.00	0.00	9.92	4.68	17.59
neuroblastoma cell line:NBsusSR	10607-108F4	48.08	9.28	30.58	2.32	2.53	2.32	2.74	0.42	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	232.57	2.05	59.82	0.00	0.00	0.00	0.00	0.19	3.35	2.05
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	104.62	1.90	41.99	0.24	0.00	0.00	0.00	0.00	0.24	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	19.32	2.53	1.74	4.91	0.16	2.38	0.48	0.00	0.00	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	62.79	38.24	13.89	7.25	4.63	9.26	11.67	0.20	0.40	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	87.74	5.09	6.36	8.26	3.81	1.27	1.91	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	125.36	8.25	4.52	13.84	13.04	14.11	14.11	0.27	0.27	11.18
neutrophil PMN, donor1	12133-128D9	0.00	0.00	29.75	0.00	0.00	44.62	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	26.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	28.41	9.47	0.00	18.94	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	24.52	19.62	184.68	1.86	0.00	2.71	1.18	0.00	1.69	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	13.61	11.21	32.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	151.97	1.28	4.17	6.73	6.09	3.53	9.94	0.32	0.32	2.24
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	63.59	7.09	4.73	15.24	4.20	6.83	7.09	11.56	0.00	0.53
nucleus accumbens, adult, pool1	10037-101F1	32.15	0.28	25.68	3.09	2.16	0.47	4.50	0.09	3.66	5.53
occipital cortex - adult, donor10196	10172-103C1	35.03	0.00	10.30	18.54	2.06	4.12	6.18	0.00	0.00	4.12
occipital cortex, adult, donor10252	10163-103B1	66.82	0.81	23.62	13.42	1.34	3.22	4.03	0.00	0.54	2.95
occipital cortex, newborn, donor10223	10355-105E4	30.94	1.46	7.28	4.73	0.73	1.46	1.82	0.00	0.73	1.46
occipital lobe, adult, donor1	10076-102A4	32.80	0.52	11.81	6.04	2.10	2.36	9.71	0.00	1.84	2.10
occipital lobe, fetal, donor1	10073-102A1	27.89	0.00	49.35	0.00	0.00	0.00	0.00	0.00	1.29	0.86
occipital pole, adult, pool1	10036-101E9	42.26	0.47	28.78	7.17	2.76	1.66	6.31	0.00	2.92	4.73
olfactory region, adult	10195-103E6	56.93	0.38	20.25	3.82	1.91	0.57	2.67	0.00	3.63	4.78
optic nerve, donor1	10277-104E7	42.02	0.00	20.01	2.00	0.00	0.00	2.00	0.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	0.00	239.09	0.00	0.11	0.00	0.34	0.00	63.45	0.00	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	0.00	150.30	25.83	5.36	1.51	18.82	4.40	1.65	3.02	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	0.00	171.36	0.00	0.17	0.17	0.17	0.00	24.72	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	0.12	251.46	0.00	0.00	0.00	0.00	0.00	10.86	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	6.47	0.29	0.00	12.35	13.82	15.58	10.88	21.17	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	19.62	0.00	0.00	6.54	1.87	3.74	2.80	4.67	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	66.16	0.00	4.45	7.21	6.57	2.33	11.66	0.42	0.00	0.21
ovary, adult, pool1	10020-101D2	84.64	8.82	11.71	12.05	5.77	1.57	9.70	0.61	1.57	5.77
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	0.73	1.28	0.00	21.27	2.75	22.73	8.43	12.83	0.00	0.00
pancreas, adult, donor1	10049-101G4	11.29	37.63	5.64	0.94	0.00	0.94	0.94	0.00	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	13.42	96.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	0.00	210.22	0.00	0.68	0.00	0.51	0.00	28.96	0.00	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	0.00	269.73	8.28	3.97	0.17	21.03	1.32	55.64	0.33	0.50
paracentral gyrus, adult, pool1	10035-101E8	32.58	0.18	23.06	6.86	3.57	1.01	6.13	0.00	3.66	4.85
parietal cortex, adult, donor10258	10373-105G4	16.88	2.94	8.07	3.67	0.73	0.73	5.14	0.00	0.00	1.47
parietal lobe - adult, donor10196	10171-103B9	30.10	0.00	21.63	12.23	0.94	0.94	7.52	0.00	0.00	3.76
parietal lobe, adult, donor10252	10157-103A4	50.45	0.29	19.95	12.26	2.00	1.71	4.56	0.00	0.29	2.28
parietal lobe, adult, pool1	10034-101E7	43.71	0.18	20.44	6.79	2.91	1.67	5.29	0.00	2.91	6.08
parietal lobe, fetal, donor1	10072-101I9	45.58	0.00	45.58	0.97	0.00	0.00	0.00	0.00	0.00	1.94
parietal lobe, newborn, donor10223	10356-105E5	31.40	3.36	10.09	5.23	3.36	0.00	5.98	0.00	1.12	5.23
parotid gland, adult	10199-103F1	27.13	41.93	6.78	4.93	3.08	11.10	1.23	1.85	0.62	0.62
penis, adult	10200-103F2	81.64	18.80	3.76	14.50	3.22	5.91	8.06	1.07	0.54	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	43.14	14.50	34.40	1.12	0.37	0.19	0.56	0.00	6.32	1.67
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	0.00	225.54	3.79	0.87	0.00	3.79	0.29	55.07	0.00	0.00
pineal gland - adult, donor10196	10179-103C8	23.22	7.10	40.64	2.58	1.29	2.58	1.94	0.00	1.29	1.29
pineal gland, adult, donor10252	10160-103A7	21.32	8.88	46.19	3.55	0.00	2.37	1.18	0.59	1.78	1.78
pineal gland, adult, donor10258	10377-105G8	21.32	14.42	21.95	3.14	0.63	0.63	1.25	0.63	1.88	1.25
pituitary gland - adult, donor10196	10180-103C9	57.67	20.24	19.22	2.02	0.00	7.08	3.04	9.11	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	53.68	32.31	10.42	3.13	2.08	2.61	3.13	16.16	0.52	1.56
pituitary gland, adult, donor10258	10378-105G9	23.83	18.73	5.96	1.70	0.85	0.85	2.55	11.92	0.00	1.70
placenta, adult, pool1	10021-101D3	13.33	58.05	7.10	9.35	3.76	3.98	2.69	5.48	0.75	12.69
plasma cell leukemia cell line:ARH-77	10840-111E3	1.85	13.24	126.86	5.03	0.53	8.48	1.19	0.00	31.52	0.66
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	53.23	81.40	5.29	4.05	2.33	5.91	0.00	13.85	0.00	0.93
pons, adult, pool1	10033-101E6	30.21	1.29	19.19	1.03	0.26	0.00	0.43	0.00	3.27	1.81
postcentral gyrus, adult, pool1	10032-101E5	42.19	0.35	26.59	8.89	2.01	2.18	6.28	0.00	4.01	4.71
promyelocytes/myelocytes PMC, donor1	12132-128D8	14.64	8.37	31.37	16.73	4.18	12.55	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	5.51	16.52	0.00	0.00	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	0.00	85.94	0.00	5.97	0.00	7.43	4.08	17.19	0.00	0.00
prostate cancer cell line:PC-3	10439-106E7	0.00	232.32	3.09	0.36	0.00	1.27	0.00	24.68	0.00	0.18
prostate, adult, pool1	10022-101D4	73.37	40.36	13.60	9.07	5.17	2.81	3.90	3.17	0.54	3.08
putamen, adult, donor10196	10176-103C5	19.36	0.24	19.83	0.47	0.24	0.24	0.24	0.00	0.00	2.60
putamen, adult, donor10252	10152-102I8	23.53	0.00	5.88	3.92	0.00	0.00	0.00	0.00	3.92	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	34.97	17.48	8.74	1.09	0.00	0.00	2.19	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	16.91	0.00	8.46	0.48	0.00	0.00	0.00	0.00	0.48	0.72
putamen, newborn, donor10223	10365-105F5	16.49	0.75	3.75	2.25	0.75	0.75	0.00	0.00	1.50	2.25
rectal cancer cell line:TT1TKB	10469-106I1	0.00	20.66	36.66	3.78	0.00	5.82	2.62	0.00	2.91	0.29
rectum, fetal, donor1	10067-101I4	294.89	57.03	25.04	4.17	0.00	4.17	8.35	0.00	1.39	15.30
renal cell carcinoma cell line:OS-RC-2	10411-106B6	1.06	134.41	0.00	7.84	0.85	14.20	3.39	29.47	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	0.00	326.81	0.00	20.71	0.83	42.25	0.83	1.66	0.00	0.00
retina, adult, pool1	10030-101E3	65.60	22.27	20.28	10.83	42.94	2.39	7.16	1.49	0.80	1.99
retinoblastoma cell line:Y79	10475-106I7	0.00	180.82	74.30	0.00	0.00	0.00	0.00	0.00	1.30	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	0.00	0.37	0.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	220.18	8.15	54.83	17.72	13.22	4.50	34.31	10.97	1.69	1.69
sacrococcigeal teratoma cell line:HTST	10695-109G2	156.12	18.95	9.09	15.91	11.37	0.76	6.06	0.00	0.00	9.09
salivary acinar cells, donor1	11771-123I7	4.21	75.26	5.02	3.88	3.72	8.90	1.13	8.09	1.13	0.81
salivary acinar cells, donor2	11772-123I8	2.34	41.86	15.70	8.54	3.72	11.84	2.75	11.98	3.99	6.20
salivary acinar cells, donor3	11773-123I9	1.99	15.89	12.58	11.92	1.99	8.61	0.00	4.63	0.66	1.32
salivary gland, adult, pool1	10093-102C3	46.90	66.92	13.15	3.43	0.00	10.30	2.86	3.43	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	11.47	5.82	7.84	20.49	5.56	3.54	10.71	0.00	3.20	1.01
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	13.40	4.58	7.88	24.57	4.82	3.17	11.64	0.00	2.23	0.47
seminal vesicle, adult	10201-103F3	61.90	97.88	10.05	6.88	1.06	2.12	3.17	1.06	1.06	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	2.43	144.05	0.00	1.94	0.49	7.04	0.24	48.10	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	0.00	54.35	0.00	1.76	0.25	2.01	0.00	25.92	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	0.00	90.32	0.00	3.01	0.00	1.00	0.00	25.09	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	24.71	80.73	13.97	0.00	0.00	0.00	0.00	7.25	2.42	0.81
signet ring carcinoma cell line:Kato III	10436-106E4	0.00	197.29	8.95	3.09	1.11	10.94	1.88	2.32	2.10	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	0.13	156.38	73.67	8.26	0.26	21.93	2.32	8.39	23.48	1.94
skeletal muscle - soleus muscle, donor1	10282-104F3	31.21	10.64	3.55	2.13	0.71	13.48	2.13	7.09	0.00	5.67
skeletal muscle, adult, pool1	10023-101D5	24.47	13.31	2.28	4.56	3.24	8.64	1.08	5.40	0.00	2.76
skeletal muscle, fetal, donor1	10066-101I3	188.94	0.00	22.11	3.02	2.01	0.00	12.06	0.00	0.00	4.02
skin, adult, donor1	10074-102A2	67.85	33.93	0.00	20.36	6.79	0.00	13.57	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	104.78	12.62	12.62	15.15	14.52	6.31	10.10	0.00	0.63	14.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	17.68	51.03	10.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	68.71	107.80	43.50	0.00	0.00	0.00	0.00	0.00	0.32	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	29.10	1.93	24.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	59.17	70.55	81.59	0.00	0.00	0.00	0.00	0.00	2.47	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	41.34	97.96	47.13	0.00	0.00	0.00	0.00	0.16	0.32	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	9.81	79.76	20.05	0.00	0.00	0.00	0.00	12.86	0.44	0.22
small intestine, adult, pool1	10024-101D6	41.81	118.49	29.74	6.45	1.07	9.08	2.39	8.72	24.61	0.96
small intestine, fetal, donor1	10064-101I1	74.69	57.49	18.67	3.44	0.74	3.69	2.95	0.00	3.19	2.21
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	0.00	61.55	0.00	0.00	0.00	0.00	0.00	13.34	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	139.31	8.27	14.22	16.02	8.01	2.58	16.28	0.00	0.78	2.84
somatostatinoma cell line:QGP-1	10781-110G7	0.00	40.47	0.00	0.00	0.00	0.00	0.00	1.61	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	111.72	1.84	30.74	1.84	1.15	2.29	0.00	0.00	1.84	2.06
spinal cord, adult, donor10252	10159-103A6	127.35	0.79	14.98	6.70	0.39	1.18	0.00	0.00	1.18	3.15
spinal cord, adult, donor10258	10369-105F9	69.87	0.69	11.76	1.38	1.38	0.00	0.00	0.00	3.46	4.15
spinal cord, fetal, donor1	10056-101H2	106.11	2.44	54.89	2.44	3.66	0.00	7.32	0.00	3.05	11.59
spinal cord, newborn, donor10223	10359-105E8	73.93	3.21	10.56	6.43	0.46	1.38	0.92	0.00	1.38	5.05
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	25.39	8.07	0.75	14.49	9.41	12.10	10.75	1.05	0.00	0.75
spleen, adult, pool1	10025-101D7	46.70	29.96	70.27	11.78	1.87	8.81	7.38	0.00	7.60	0.44
spleen, fetal, pool1	10044-101F8	82.39	17.88	79.14	10.33	1.03	5.24	6.83	0.32	9.69	5.64
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	0.00	5.69	211.06	1.35	0.00	1.24	0.00	0.00	44.82	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	7.03	64.18	7.78	3.23	0.00	3.80	0.19	13.29	0.57	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	9.78	41.93	1.05	1.75	1.40	0.70	0.00	3.84	0.00	1.75
squamous cell carcinoma cell line:T3M-5	10616-108G4	0.00	106.72	0.00	0.00	0.00	0.00	0.00	7.04	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	0.11	170.30	0.00	3.15	0.00	5.40	0.79	21.27	0.00	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	0.42	63.12	0.00	0.42	0.00	1.69	0.42	2.54	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	0.42	150.61	0.00	11.85	0.85	21.58	4.65	14.38	0.00	0.00
stomach, fetal, donor1	10062-101H8	136.70	59.81	21.36	4.27	0.00	1.07	3.20	1.07	0.00	10.68
submaxillary gland, adult	10202-103F4	47.28	43.87	26.21	1.71	0.57	5.70	1.71	2.85	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	73.53	0.83	17.45	3.32	0.62	1.04	0.83	0.00	0.62	0.21
substantia nigra, adult, donor10258	10371-105G2	47.07	0.00	11.38	1.03	0.00	0.00	0.00	0.00	2.07	0.52
substantia nigra, newborn, donor10223	10358-105E7	99.63	0.71	9.89	4.95	0.71	2.83	2.12	0.00	0.71	3.53
synovial sarcoma cell line:HS-SY-II	10441-106E9	73.36	8.02	64.88	6.65	5.96	3.67	16.28	2.06	0.92	3.44
temporal lobe, adult, pool1	10031-101E4	44.08	1.10	30.86	7.29	4.07	1.44	5.76	0.00	4.41	7.88
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	30.63	0.00	67.67	0.00	0.71	0.00	0.71	0.00	2.85	2.85
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	23.30	5.27	67.69	0.00	0.00	0.44	0.44	0.00	4.83	3.08
tenocyte, donor1	11763-123H8	136.15	5.24	4.19	8.03	39.10	2.44	9.43	1.75	0.00	6.28
tenocyte, donor2	11765-123I1	74.78	2.29	1.14	7.63	27.09	0.76	6.87	0.38	0.00	1.91
tenocyte, donor3	11768-123I4	224.99	5.93	4.82	16.68	34.84	4.08	8.53	0.37	2.22	31.88
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	140.73	36.88	70.70	0.51	0.00	0.34	0.51	0.00	10.88	2.04
teratocarcinoma cell line:NCR-G1	10798-110I6	243.86	20.50	31.75	0.15	0.00	0.00	0.00	4.93	3.08	0.15
teratocarcinoma cell line:PA-1	10807-111A6	75.78	10.38	43.55	2.01	0.31	3.56	2.32	1.39	7.75	1.39
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	23.23	60.81	51.79	3.81	1.52	7.62	6.09	9.77	11.93	0.76
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	35.93	29.12	18.15	0.00	0.00	0.00	0.00	1.13	3.03	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	16.80	28.36	23.23	6.98	0.44	10.91	6.87	6.65	3.38	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	39.41	41.04	4.89	0.00	0.00	0.00	0.33	0.00	0.98	0.00
testis, adult, pool1	10026-101D8	114.57	11.49	18.58	4.72	3.22	1.29	1.61	0.00	8.38	2.36
testis, adult, pool2	10096-102C6	147.96	28.87	49.17	0.45	0.45	1.35	1.35	0.00	11.28	1.35
thalamus - adult, donor10196	10168-103B6	62.93	2.21	37.54	0.00	0.00	2.21	0.00	0.00	0.00	3.31
thalamus, adult, donor10252	10154-103A1	57.20	0.00	18.60	0.78	0.16	0.00	0.00	0.00	0.63	2.50
thalamus, adult, donor10258, tech_rep1	10370-105G1	36.95	0.00	6.16	1.54	0.00	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	48.25	0.82	7.91	0.82	0.00	0.00	0.00	0.00	0.99	0.82
thalamus, newborn, donor10223	10366-105F6	21.29	0.00	10.36	1.73	0.58	0.58	0.58	0.00	1.15	2.30
throat, adult	10209-103G2	34.95	28.21	12.98	3.99	1.00	9.24	3.99	3.25	1.00	1.50
throat, fetal, donor1	10061-101H7	106.95	25.90	17.67	3.35	1.52	2.44	3.96	1.83	0.30	3.05
thymic carcinoma cell line:Ty-82	10803-111A2	16.10	13.51	31.20	0.00	11.53	0.00	0.00	0.00	0.20	0.00
thymus, adult, pool1	10027-101D9	138.98	32.41	375.69	0.60	0.99	1.49	0.30	0.99	17.70	1.09
thymus, fetal, pool1	10043-101F7	234.82	27.53	241.58	2.60	0.94	2.18	0.62	1.35	14.44	2.70
thyroid carcinoma cell line:KHM-5M	10776-110G2	0.00	73.93	1.86	11.43	3.32	15.02	5.72	5.98	0.00	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	4.33	41.49	0.56	4.19	0.00	2.79	1.68	1.26	0.00	0.28
thyroid, adult, pool1	10028-101E1	28.37	48.15	1.49	3.55	1.59	2.24	0.75	0.28	0.09	0.84
thyroid, fetal, donor1	10060-101H6	69.08	48.25	3.69	6.86	1.05	3.69	2.90	0.53	0.00	2.90
tongue epidermis (fungiform papillae), donor1	10288-104F9	61.59	76.99	3.08	9.24	6.16	36.96	0.00	0.00	0.00	12.32
tongue, adult	10203-103F5	30.70	36.98	5.58	9.30	2.79	5.12	1.86	2.56	1.16	2.09
tongue, fetal, donor1	10059-101H5	67.39	9.46	5.91	0.79	1.18	1.97	0.79	1.18	0.00	1.97
tonsil, adult, pool1	10047-101G2	43.38	43.78	146.96	4.71	1.10	8.21	3.01	1.90	18.23	1.10
trachea, adult, pool1	10029-101E2	37.71	54.23	9.24	10.22	4.83	11.37	2.70	22.17	1.47	1.23
trachea, fetal, donor1	10058-101H4	82.71	32.31	6.16	4.23	1.92	6.16	4.23	1.92	1.92	4.62
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	136.75	14.17	6.38	21.26	18.42	19.13	12.40	0.35	1.77	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	0.00	211.24	0.00	1.22	0.41	4.56	0.91	19.45	0.00	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	0.16	40.90	0.00	5.33	1.57	8.46	8.62	2.66	0.00	0.00
tridermal teratoma cell line:HGRT	10694-109G1	214.99	32.34	20.93	24.73	5.71	7.61	11.42	0.00	3.81	5.71
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	0.08	79.15	0.00	3.64	0.93	10.50	1.44	24.04	0.00	0.00
umbilical cord, fetal, donor1	10057-101H3	58.42	10.43	4.17	10.43	2.09	0.00	8.35	2.09	0.00	6.26
uterus, adult, pool1	10100-102D1	132.75	10.58	12.63	12.80	12.46	1.19	11.60	1.88	1.37	8.19
uterus, fetal, donor1	10055-101H1	174.57	14.33	16.38	9.21	2.05	0.51	9.73	2.05	0.51	7.17
vagina, adult	10204-103F6	76.25	19.39	5.17	27.79	9.69	4.52	1.94	0.00	0.00	0.00
vein, adult	10191-103E2	68.83	7.01	106.53	2.63	1.10	1.97	1.53	0.22	9.86	2.41
xeroderma pigentosum b cell line:XPL 17	10563-108A5	2.94	40.86	63.55	9.35	0.80	14.95	1.60	0.00	7.21	0.00